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ANTIMICROBIAL RESISTANCE IN FEEDLOT CATTLE 
 
 
Objectives: To develop and validate methodological components of a model for 
surveillance of antimicrobial use and resistance in feedlot cattle.   
 
Methods: A web-based survey of participants knowledgeable and interested in 
antimicrobial use in beef feedlots was used to solicit responses regarding appropriate 
metrics for quantifying, analyzing, and reporting antimicrobial exposures.  The 
accuracies of two susceptibility tests commonly recommended for surveillance programs 
were determined using stochastic latent class analysis.  Multivariable logistic and linear 
regression was used to investigate associations between exposures to antimicrobial drugs 
and antimicrobial resistance. 
 
Results: When reporting antimicrobial use in the context of antimicrobial resistance, 
survey participants believed that the Animal Defined Daily Dose metric was the most 
accurate.  The two susceptibility tests investigated had comparable accuracies for the 
antimicrobial drugs tested.  Exposure to parenteral tetracycline in the study feedlots was 
associated with resistance to tetracycline; however, exposures to all other classes of 




Conclusions: Appropriate metrics for reporting and analyzing antimicrobial resistance are 
necessary to accurately investigate associations between use and resistance, though 
clarity of what the metric represents may be lost.  Testing of susceptibility in surveillance 
programs is equally valid by way of disk diffusion testing.  Multivariable logistic 
regression was an appropriate and useful method to investigate associations between use 
and resistance.  Parenteral exposures to antimicrobials did not drive antimicrobial 
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 The three projects presented in this dissertation contributed to a large multi-
institution collaborative effort to develop a longitudinal antimicrobial resistance and use 
surveillance program for the feedlot sector in Canada.  The goal of this large-scale effort 
was to develop and validate a practical model for monitoring antimicrobial susceptibility 
in populations of feedlot cattle.  Lead investigators represented five universities 
(Colorado State University, University of Calgary, University of Guelph, University of 
Lethbridge, and University of Saskatchewan), provincial and federal Canadian 
government (Alberta Agriculture Food, Rural Development Food Safety Division, 
Agriculture and Agri-Food Canada, and Public Health Agency of Canada), and one 
private veterinary company (Feedlot Health Management Services) which managed the 4 
large, commercial feedlots where the surveillance program was piloted.  
In order to implement effective resistance control strategies, surveillance systems 
must evaluate accurate and reliable data.  Prior to collecting this data the methodology 
related to sampling, shipping, testing, analyzing, and reporting should be validated for 
efficiency and accuracy.  The projects of this dissertation were focused on three specific 








1) How should antimicrobial use data be quantified for analysis of antimicrobial 
resistance and for reporting? (Chapter 2) 
2) What is an appropriate testing method for determining susceptibility? (Chapter 3) 
3) How should analysis be conducted to investigate associations between exposure 
to antimicrobial drugs and antimicrobial resistance? (Chapter 4) 
 
Each of these questions was investigated as an independent project.  Objectives, 
methods and materials, results, and discussion for each project are presented separately in 
Chapters 2-4.  Interpretive summaries for each chapter and the final Conclusions 
(Chapter 5) describe how the project relates back to the aim of the large-scale 
collaborative effort and the broader implications of the work.  Other research 
investigating the development, dissemination, and persistence of antimicrobial resistance 
has been conducted globally for decades.  A review of the previous work and existing 
gaps in knowledge related to antimicrobial resistance surveillance in feedlot cattle is 
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Antimicrobial resistance is an emerging global threat to human and animal health 
(Levy and Marshall 2004).  Awareness of this problem is more widespread due to highly 
publicized anecdotes about “superbugs” which defy treatment, but the problem itself is 
nothing new (Newell et al. 2010).  Within 2 decades of the discovery of penicillin, 
researchers were already warning that misuse could lead to selection and propagation of 
mutant resistant forms of bacteria (Fleming 1929; Levy 2002).  One response to these 
resistant variants in the past has been the application of new and “better” drugs.  Different 
antimicrobials were discovered and synthesized in the latter part of the 20th century on a 
regular basis.  However, no new antimicrobials are currently on the horizon that can 
adequately compensate for the loss in susceptibilities to existing antimicrobials (The 
Alliance for the Prudent Use of Antibiotics 2005).  A “post-antibiotic” era in which no 
antimicrobials will be able to combat simple infections is the ultimate fear driving efforts 
to understand the complexities of antimicrobial resistance (Cohen 1992).  It has been 
suggested that resistances to antimicrobials which develop on the local scale left 
unmanaged will lead to an untenable global problem and these once powerful will be 
rendered useless (Levy 2001). 
 The use of antimicrobials is the hypothesized major driving force for the 
occurrence of antimicrobial resistance (Figure 1, adapted from Barbosa and Levy 2000).  
Theoretically, susceptible bacteria in the presence of an antimicrobial are eliminated from 
heterogeneous populations of bacteria, while the resistant and even marginally 
susceptible bacteria are left to proliferate.  However, other factors such as overuse of 
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disinfectants and heavy metals in the environment are recognized as having an influence 
as well (Levy 1998; Levy 2002).  Beyond the initial use of antimicrobials, post-
therapeutic effects and residues in the environment are also pressures which select for 
resistant variants of bacteria over susceptible ones (Gibbs et al. 2006; Levy and Marshall 
2004). 
Antibiotic Use Antibiotic Resistance
Production intensity
Feed sources














Figure 1:  Relationship between antibiotic use and development of resistance.  
Antibiotic use is the main factor in the forward process, i.e. selection of resistance, but 
other factors can influence that relationship.  Factors dependent on management of 
animals are represented above the horizontal arrow, while factors related to the antibiotic 
itself and the genetic basis of resistance are represented below the horizontal arrow 
(adapted from Barbosa and Levy 2000). 
 
 Dissemination of antimicrobial resistance through clonal spread as well as by 
transfer of resistance genes is of greater concern than the initial development (van den 
Bogaard and Sobberingh 2000).  New genetic methods are needed to trace antimicrobial 
resistance within and between host populations (O’Brien 2002).  Though antimicrobial 
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resistance can spread through many different routes, the transmission from agricultural 
animals to humans is often scrutinized (Ferber 2000; Shea 2003).  A concerning scenario 
would be that the antimicrobial drugs used in food-producing animals would ultimately 
lead to preventable health problems in consumers.  A direct route between exposures to 
antimicrobial drugs in food animals to human health problems is unlikely beyond 
anecdotes of people working or living closely with the animals (Angulo et al. 2004; Fey 
et al. 2000).  However, human and animal microbial ecosystems do overlap in various 
relationships and efforts to untangle the complexity should also take an ecological 


































Figure 2:  Network of resistance. Ecological relationships between antibiotic-resistant 
bacteria and resistance genes: selective pressures, main reservoirs, and routes of 





The concerns about human health related to antimicrobial use are polarized 
around 2 sets of issues (Barton 1998): 
1) Issues that concern proponents of the view that antibiotic use in animals impinges 
on human health include: 
 The prevalence of antimicrobial resistant bacteria in food-producing animals 
 Evidence that resistant organisms and genes encoding resistance can be passed 
between animals and people and into the environment 
 The large amount of antimicrobials fed as growth promotants or prophylactic 
treatments in animals 
 The use in animals of antimicrobials that are used therapeutically in human 
medicine or which select for cross-resistance to antimicrobials used in human 
medicine, 
2) Arguments for the view that antimicrobial resistance in human pathogens stems 
from improper use of those drugs in human medicine include: 
 Apart from growth promotants, antimicrobials are used much less in animals 
than in people 
 Use of antimicrobials in animals has not led to multi resistance problems seen 
in human medicine 
 The use of antimicrobials as growth promotants is important to the economics 
and sustainability of intensive livestock production and preventive and 
therapeutic treatments are essential for animal welfare. 
Unfortunately, sound evidence regarding the above issues is sparse and the absence of 
proof cannot be interpreted as the proof of absence (McGeer 1998).  Placing emphasis on 
the direction of pathogens spreading from food-producing animals to humans may lead 
investigators to overlook equally important components of the ecology of these 
pathogens (Barber 2001). 
 Research is needed in many areas regarding the development, dissemination, and 
persistence capabilities of antimicrobial resistant organisms and resistance determinants 
(McDermott et al 2002; McEwen et al. 2008).  Food safety concerns have driven 
investigations into the ability of foodborne bacteria to contaminate all steps in the 
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production of animal products.  In 21 Alberta feedlots, common foodborne bacterial 
pathogens were rarely detected in carcass and environmental samples (Donkersgoed et al. 
2009).  Documentation of the transmission of resistant organisms from animals to food 
products to humans is limited (Piddock 1996).  If contamination does occur, data have 
shown that antimicrobial resistant E. coli can enter the food chain regardless of whether 
or not cattle were administered growth promotants (Alexander et al. 2010).  The pathway 
between the development of resistance in food animals and health threats involves many 
steps.  Likely, the overall probability of transmission through all of these steps is low.  
However, comprehensive risk assessments are still needed to document these 
probabilities (Phillips et al. 2004). 
The issue of antimicrobial resistance is multi-faceted and cannot be understood 
with only one approach.  However, this overwhelming problem should be attacked one 
“patch” at a time (Levy 2002).  Many calls for surveillance in agricultural populations to 
monitor antimicrobial resistance have been made (Aarestrup 2005; Anderson 1999; 
McEwen and Fedorka-Cray 2002; The Alliance for the Prudent Use of Antibiotics 2005).  
Data from these surveillance programs would theoretically document baseline levels of 
resistance and would allow earlier response to increasing resistance trends.  Responding 
to low levels of resistance rather than high levels may be crucial since resistance genes 







 In the past, systems monitoring the usage of antimicrobial drugs may not have 
been sufficient for specifically documenting and responding to antimicrobial resistance.  
To comply with drug regulations, these early systems were less focused on antimicrobial 
resistance than they were on detecting residues in food, allergic reactions, and drug 
toxicities (Black 1984).  However, recent efforts with specific focus on antimicrobial 
resistance have been conducted as individual cross-sectional studies as well as large 
scale, ongoing national programs (Aarestrup 2004; Bager 2000; Bronzwaer et al. 2002; 
Hendriksen et al. 2008; Kaspar 2006).  Examples of the organizations monitoring 
antimicrobial resistance and use on the national scale include: 
 
 ARBAO II  Antibiotic resistance in bacteria of animal origin—II (Europe) 
 EARSS European Antimicrobial Resistance Surveillance System  
 ESAC  European Surveillance of Antimicrobial Consumption  
 DANMAP Danish Integrated Antimicrobial Resistance 
Monitoring and Research Programme 
 JVARM Japanese Veterinary Resistance Monitoring System  
 STRAMA Swedish Strategic Programme Against Antibiotic Resistance 
 NARMS National Antimicrobial Resistance Monitoring System (USA) 
 CIPARS Canadian Integrated Program for Antimicrobial Resistance 
Surveillance 
 
Additionally, the Global Advisory on Antibiotic Resistance Data (GAARD) with the 
Initiative of the Alliance for the Prudent Use of Antibiotics (APUA) has produced 
comprehensive reports on the state of antimicrobial susceptibility internationally.  The 
efforts of these monitoring systems have provided crucial data for their nations.  
However, the World Health Organization (WHO) and the World Organization for Animal 
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Health (OIE) have both made calls for standardization of these programs to allow better 
comparisons of the global state of antimicrobial resistance and use. 
 Though harmony is needed among systems, separate surveillance programs with 
different goals are inevitable.  In developing countries, routine and efficient methods for 
prevention strategies conducted in developed countries may not be practical (Vlieghe et 
al. 2010).  Surveillance in critical care and tertiary care facilities often is more intensive 
since nosocomial infections have a high probability of involving antimicrobial resistance 
complications (Ogeer-Gylels et al. 2006).  Despite the typical perception that companion 
animals are not significant reservoirs for antimicrobial resistance, surveillance programs 
tracking resistance in these populations are also important (DeVincent and Reid-Smith 
2006; Guardabassi et al. 2004).  
Many surveillance programs are currently in operation, yet optimal methodology 
for conducting surveillance is unknown.  Key features have been suggested for 
surveillance such as having a statistically valid sampling program, avoiding “copy 
strains,” and using standardized methodology in testing susceptibility (Wallman 2006).  
Also, due to the need to elucidate associations with resistance, these surveillance 
programs should document quantities of antimicrobial use (Singer et al. 2006; Bager 
2000; Szhotnicki 2004).  Beyond the details of program components, overall the greatest 
current weakness concerning surveillance is simply a lack of adequate data and 





ANTIMICROBIAL RESISTANCE IN CATTLE 
 
 The level of antimicrobial resistance in cattle is relatively low according to studies 
in dairy, cow calf beef, and feedlot herds.  Less than 10% of Pasteurella spp. and 
Mannheimia haemolytica isolates recovered from healthy calves on 16 dairy herds were 
able to grow on oxytetracycline-selective media (Catry et al. 2006).  Cattle with 
respiratory infections also had overall low levels of resistance in isolates of respiratory 
pathogens, except for resistance to sulfamethoxazole in P. multocida and M. haemolytica 
and resistance to ampicillin in M. haemolytica (Schwarz et al. 2004).  The majority of 
commensal E. coli and Salmonella spp. recovered from the feces of dairy cows on farms 
in 21 states had no resistance to a broad range of antimicrobial drugs (Lundin et al. 2008).   
Resistances which do commonly exist in these populations are not classified as 
being of very high importance to human health.  Genetic investigations of antimicrobial 
resistance in healthy lactating dairy cows have found that E. coli is an important reservoir 
for tetracycline and other antimicrobial resistance determinants (Sawant et al. 2007).  
Investigations of calves and cow-calf pairs found that resistance was rare to 
antimicrobials classified as being of very high importance to human medicine.  The most 
common resistances in these populations were to tetracycline, sulfamethoxazole, and 
streptomycin (Gow et al. 2008a).  Cow calf farms were at lower risk than feedlots for 
having E. coli isolates that were resistant to tetracycline, sulfamethoxazole, and 
streptomycin.  No resistances to ceftriaxone or ciprofloxacin were observed in the feedlot 
isolates and less than 1% of isolates were resistant to gentamicin, nalidixic acid, and 
ceftiofur (Carson et al. 2008b).  A separate study also found that resistances to 
tetracycline and sulfamethoxazole were common in feedlots (Dargatz et al. 2002).  
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However, most isolates of Salmonella recovered from pen floor samples at these 100 
feedlots were susceptible to all antimicrobials tested.  Despite lacking evidence of direct 
threats to human health by way of antimicrobial resistance in these populations, the 
perception is that the emergence of such a problem is possible and should be closely 
monitored. 
 Molecular investigations have revealed multiple mechanisms of resistance that are 
both transferable (plasmids and transposons) as well as permanent (chromosomal 
changes) (Wilson 1990).  Plasmids and transposons have a role in the spread of the 
resistant genes in Pasteurella and Mannheimia isolates (Kehrenberg et al. 2001).  
Plasmids also have been documented to conjugate with commonly between E. coli and 
Salmonella.  In an outbreak investigation of salmonellosis in calves, plasmids conferring 
resistance to apramycin and several other antibiotics were transferred by conjugation in 
vitro from E. coli to S. typhimurium (Hunter et al. 1992).  Recently, a novel mechanism 
(radical-induced mutagenesis) has been documented for the development of resistance to 
antimicrobials when sublethal levels of different antimicrobials are applied (Kohanski et 
al. 2010).  Unfortunately, traditional testing methodologies which can identify 
susceptibilities in antimicrobials may not be able to detect novel resistance phenotypes 
(Tenover 2001).  Selective pressures on bacteria can encourage the development of novel 
resistance genes or can help establish acquired resistance traits (Kehrenberg et al. 2001).  
However, the genes themselves are not responsible for the greater fitness advantage of 
antimicrobial resistant E. coli in calves.  Other factors such as the farm environment and 
diet exert selective pressures (Khachatryan et al. 2006). 
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 Multiple factors participate in establishing and maintaining antimicrobial 
resistance.  Feed can harbor genetic elements associated with resistance for feedlot cattle 
by way of contamination with E. coli and Salmonella or residual determinants from feed 
components such as wet distillers grain with solubles (Dargatz et al. 2005; Jacob et al. 
2010).  The environments of intensively managed animals such as feedlot cattle can 
harbor resistant bacteria and resistance determinants (Alexander et al. 2009; Berge et al. 
2010; Gibbs et al. 2006; Holzel et al 2009).  Resistance occurrence also varies dependent 
on certain host factors such as age (Berge et al. 2010; Gow et al. 2008a).  Environmental 
and host factors likely interact with other selective pressures and it is unlikely that any 
single exposure factor can wholly account for the development and maintenance of 





INDIRECT ASSOCIATIONS BETWEEN ANTIMICROBIAL USE AND 
RESISTANCE 
 
 Within the web of factors which are associated with antimicrobial resistance, 
antimicrobial use is hypothesized to be a significant component.  A classic model for 
investigating associations between antimicrobial use and resistance indirectly has been to 
compare resistance in production using conventional practices which include the use of 
antimicrobials versus production in populations which have specifically excluded the use 
of antimicrobials.  These studies hypothesize that if antimicrobial use is significantly 
associated with antimicrobial resistance, then differences in resistance will be detected 
between the production methods.  An investigation of Campylobacter spp. on swine 
farms found no difference in the prevalence of this bacterium between antimicrobial-free 
and conventional production methods, but did find a lower prevalence of antimicrobial 
resistance in the antimicrobial free farms (Rollo et al. 2010).  Though these authors noted 
that resistances tended to decline as the number of years that a farm was antimicrobial-
free increased, they suggested that investigation of other interventions to reduce 
resistance levels was warranted.  Conversely, investigations of antimicrobial 
susceptibility in organic (i.e., no or severely limited antimicrobial use) and conventional 
dairy herds have documented that resistances in Campylobacter spp. were no different 
between the production methods (Sato et al. 2004).  Interestingly, these authors did find 
that calves had higher levels of resistance than cows supporting previous statements 
about other factors contributing to resistance.  Additional comparison studies between 
these dairies revealed that resistance prevalence in E. coli isolates were different for 7 
antimicrobials, but not significantly different for 10 other antimicrobials (Sato et al. 
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2005).  Controlling for age, conventional dairy farms had significantly higher rates of 
resistance to ampicillin, streptomycin, kanamycin, gentamicin, chloramphenicol, 
tetracycline, and sulfamethoxazole.  Production practices of swine and dairy operations 
are different from that of feedlot cattle, so extrapolation of these conclusions to feedlot 
cattle may be limited.   
A recent study compared resistances in pens of feedlot cattle reared using 
conventional practices with those being fed without antimicrobial exposures (Morley et 
al. 2011).  These authors concluded that conventional feedlot production methods 
(including parenteral and in-feed use of antimicrobials) do not predictably or uniformly 
increase the prevalence of a resistance in non-type specific E. coli when compared to 
production methods which restrict exposure to antimicrobial drugs.  Additionally, though 
no tetracyclines were administered in these populations of feedlot cattle, the resistance to 
tetracycline increased temporally through the feeding period.  Similarly, in a separate 
study, resistance to streptomycin, sulfamethoxazole, and tetracycline increased 
significantly from arrival to mid-point during the feeding period and persisted until 
market-readiness (Carson et al. 2008b).  Therefore, temporal and transient trends in the 
prevalence of resistance, which vary between antimicrobial drugs, might account for 
resistance levels rather than exposure to antimicrobial drugs.  Conflicting conclusions 
from these comparison studies support the need for more direct investigations in the 
association between antimicrobial use and resistance.  Well-designed association studies 
are needed to shed more light on the lesser understood quantitative aspects of 




DIRECT ASSOCIATIONS BETWEEN ANTIMICROBIAL USE AND 
RESISTANCE  
 
Evidence for and against direct associations between the use of antimicrobial 
drugs and antimicrobial resistance has been documented.  An early study tracking 
antimicrobial use in feedlot calves and relating it to levels of resistance revealed that 
therapy with a particular antimicrobial in the week prior to death, increased the level of 
resistance to P. haemolytica to that antimicrobial (Martin et al. 1983).  These authors also 
made observations that resistance to penicillin, tetracyclines, and chloramphenicol 
occurred more frequently together than expected by chance alone.  Injectable 
oxytetracycline in addition to in-feed chlortetracycline administered to cattle was 
associated with an increase in the prevalence of resistance in commensal E. coli to 
chloramphenicol and sulfisoxazole, but no other tested antimicrobials (O’Connor et al. 
2008).  Exposure to chlortetracycline for feedlot cattle was associated with a temporary 
increase in the recovery of resistant E. coli and Enterococcus isolates (Platt et al. 2008).  
Also of note, the ceftiofur-resistant E. coli isolates in this study actually declined during 
the exposure to chlortetracycline.  The transient expansion of multiple-resistant variants 
of E. coli was found to be associated in a separate study with the parenteral 
administration of ceftiofur crystalline-free acid to feedlot steers (Lowrance et al. 2007).  
Susceptibility returned to baseline levels approximately 2 weeks after completion of the 
ceftiofur crystalline-free acid administration.   Positive associations between in-feed as 
well as injectable tetracycline were found for resistance to tetracycline, streptomycin, and 
sulfadiazine among non-type specific E. coli in feedlot cattle (Rao et al. 2010).  However, 
these authors concluded that the differences noted were relatively small and of 
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questionable practical relevance.   In cattle receiving antimicrobials for metaphylaxis and 
treatment in the absence of in-feed macrolides and tetracyclines, no associations were 
found between antimicrobial use and resistance in recovered isolates of E. coli (Checkley 
et al. 2008).  A lack of any associations in Salmonella isolates between resistances and 
the presence of antimicrobials in feed were noted in another study of feedlot cattle 
(Dargatz et al. 2002).  Specific investigation into resistances in E. coli isolates recovered 
from feedlot cattle given subtherapeutic administration of tetracycline in combination 
with sulfamethazine revealed associations with tetracycline and ampicillin resistances 
(Alexander et al. 2008).  However, these authors acknowledged that additional 
environmental factors such as diet may be related to these resistances. 
 The studies described above specifically investigating the association between 
antimicrobial use and antimicrobial resistances in cattle do provide some evidence that 
associations exist in these populations.  However, as always it is important to keep in 
mind that association is not causation and further studies are warranted that can account 







 Antimicrobial drugs are crucial to the health and management of agricultural 
populations of animals.  Administration of antimicrobials in feedlots is largely for the 
prevention of liver abscesses and the prevention and treatment of bovine respiratory 
disease.  On all feedlots included in a representative national study, bovine respiratory 
disease was the most common disease condition and nearly all of the feedlots included 
injectable antimicrobial drugs (most commonly tilmicosin, florfenicol and tetracyclines) 
as part of an initial course of treatment for bovine respiratory disease (NAHMS 1999).  If 
the therapeutic regimen used for initial treatment failed to result in a favorable response, 
84% of the feedlots changed their choice of antimicrobial.  Large feedlots were more 
likely than small feedlots to administer antimicrobials metaphylactically to groups of 
cattle to prevent bovine respiratory disease, though overall only 10.4% of cattle placed in 
feedlots were administered antimicrobials for this reason.  Many (83.2%) of the surveyed 
feedlots also included antimicrobials in feed or water as a health or production 
management tool.  A Canadian study quantified the commonly used antimicrobials by 
injection (oxytetracycline, penicillin, macrolides, florfenicol, and spectinomycin), in feed 
(monensin, tylosin, lasolocid, and tetracyclines), and in water (lincomycin-
spectinomycin, chlortetraycline, and oxytetracycline) (Carson et al. 2008a).  Though 
usage of antimicrobials is common in North American feedlots, veterinarians weigh 
multiple factors in the decision to utilize appropriate antimicrobials.  A survey of feedlot 
veterinarians indicated that the effects of moral beliefs on behavioral beliefs were 
contingent on the condition such as the level of risks associated with treating or not 
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treating cattle and the effectiveness of antimicrobials in acute illness (McIntosh et al. 
2009).   
 The ability of antimicrobials to treat or prevent an indication (efficacy) and the 
ability to do this well (effectiveness) are major components in the decision to use these 
drugs.  Considering the health risks associated with antimicrobial resistance and the 
potential association with antimicrobial drug use, evidence of usefulness of these drugs is 
most definitely necessary.  The approval process for new animal drug applications 
through the Food and Drug Administration (FDA) requires that antimicrobial drugs meet 
standards of effectiveness and safety.  However, further independent field trials in the 
feedlot sector often follow FDA approvals to further evaluate antimicrobials.  Tilmicosin 
and oxytetracycline in feedlot cattle have been shown to be useful as prophylactic (given 
prior to an expected infection) antimicrobial drugs for reducing morbidity due to bovine 
respiratory disease (Donkersgoed 1992; Frank and Duff 2000; Merrill et al. 1994; 
Schunicht et al. 2000a).  Given metaphylatically (at the time of an expected infection) 
antimicrobials such as florfenicol and tulathromycin are also useful in managing bovine 
respiratory disease (Booker et al. 2007; Duff and Galyean 2007; Frank et al. 2002).  
Administration of antimicrobials for treatment of bovine respiratory disease is primarily 
more effective if disease is recognized early (Cusack et al. 2003).  The drugs which have 
been found to be effective as treatment of undifferentiated fever include tulathromycin, 
florfenicol, tilmicosin, trimethoprim-sulfadoxine, oxytetracycline, penicillin, and 
ceftiofur (Batemen et al. 1990; Booker et al. 1997; Guichon et al. 1993; Harland et al. 
1991; Jim et al. 1992; Jim et al. 1999; Mechor et al. 1988; Schunicht et al. 2007).  Many 
of these antimicrobials have been compared to one another to assert the comparable or 
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superior efficacy of one drug to another.  The antimicrobial drugs discussed above also 
improve growth efficiency which is a characteristic in feedlot production that is highly 
regarded (Gorham et al. 1990; Merrill et al. 1994; Encinias et al. 2006; Schumann et al. 
1990; Schunicht et al. 2002b).  Cost effectiveness is another crucial characteristic of these 
antimicrobials in the context of antimicrobial resistance and has also been investigated 
for these drugs (Perrett et al. 2008; Booker et al. 2006; Schunicht et al. 2002a).  
 The impact of antimicrobial resistance on bovine respiratory disease is not well 
established (Watts and Sweeney 2010).  As previously described in the antimicrobial 
resistance section, resistance in feedlot cattle is relatively low.  Despite more common 
resistances to tetracycline in feedlot populations, the efficacy of tetracyclines does not 
seem to be compromised (Rao et al. 2010).  However, a deficiency in information about 
antimicrobial use complicates antimicrobial research and proper risk assessments are 
needed to evaluate the potential loss of usefulness of antimicrobial drugs (Fraser et al. 
2004; McEwen and Singer 2006).  Additionally, since the microbial ecologies of animals 
and humans are intertwined, any shared loss of usefulness (loss of susceptibility) 




ANTIMICROBIAL USE POLICY 
 
 In the United States, the safety of drugs in target species was first regulated by the 
Federal Food, Drug, and Cosmetic Act in 1938.   Among many amendments to this act, 
ones pivotal in the context of antimicrobial use in feedlot cattle categorized prescription 
and over-the-counter drugs separately (1951) and provided for the authority of the Food 
and Drug Administration Center for Veterinary Medicine (FDA-CVM) (1962).  More 
recently, the Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA) began to 
regulate extra-label use of drugs by veterinarians.  A current bill (Preservation of 
Antibiotics for Medical Treatment Act of 2009 [PAMTA]) is still in the first step of the 
legislative process and has the objective to preserve the effectiveness of medically 
important antibiotics used in the treatment of human and animal diseases (Wren 2007).  
Though not a formal regulation requirement, the Food Animal Residue Avoidance and 
Depletion Database (FARAD) is a national tool sponsored by the United States 
Department of Agriculture which aids in avoiding illegal drugs in foods of animal origin.  
An extensive review of the scientific evidence related to antimicrobial resistance threats 
to human health due to the use of antimicrobial drugs in animals was conducted by a 
scientific advisory panel known as “The Facts about Antimicrobials in Animals and the 
Impact on Resistance” (FAAIR 2002).  This collection of researchers has made the 
following recommendations: 
1. Antimicrobial agents should not be used in agriculture in the absence of disease 
2. Antimicrobials should be administered to animals only when prescribed by a 
veterinarian 
3. Quantitative data on antimicrobial use in agriculture should be made available to 
inform public policy 
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4. The ecology of antimicrobial resistance should be considered by regulatory 
agencies in assessing human health risk associated with antimicrobial use in 
agriculture 
5. Surveillance programs for antimicrobial resistance should be improved and 
expanded 
6. The ecology of antimicrobial resistance in agriculture should be a research 
priority 
 
In Canada, regulation of veterinary biologics and medicated feeds is done by the 
Canadian Food Inspection Agency (CFIA).  The Veterinary Drugs Directorate (VDD) is 
the branch of Health Canada that approves drug products and determines withdrawal 
times.  Currently, extra-label use of drugs by veterinarians is not regulated by any 
legislation, though Canadian offices of the global FARAD aids in determining 
withdrawal times for such extra-label drug use.  The list of drugs prohibited in food 
animals in Canada is different from that of the United States (Dowling 2003). 
International organizations have also addressed issues of antimicrobial resistance.  
The World Organization for Animal Health (OIE) has published guidelines for veterinary 
pharmaceutical industry, veterinary practitioners, dispensing pharmacists, and farmers 
with the objective “to maintain antibiotic efficacy, to avoid dissemination of resistant 
bacteria or resistance determinants, and to avoid the exposure of humans to resistance 
through food” (Anthony et al. 2001).  The World Health Organization (WHO) ranks and 
updates antimicrobials according to their importance in human medicine in efforts to 
develop risk management strategies (Collignon et al. 2009).  These two organizations 
also have made a joint report with the Food and Agriculture Organization (FAO) on 
Critically Important Antimicrobials (2007).  This meeting was a continuation of another 
meeting of the three organizations in 2003 after recommendations from the Executive 
Committee of the Codex Alimentarius Commission were discussed in 2001.  Among 
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many recommendations from the Report of the Joint FAO/WHO/OIE Expert Meeting on 
Critically Important Antimicrobials in 2007, one relevant to current surveillance efforts in 
feedlot cattle is: 
5. Antimicrobial resistance monitoring of foodborne pathogens and 
commensals (animal, human, food and commodity) should be 
implemented by all countries considering risk management measures, to 
enable the detection of hazards and accurately assess the success of 
selected interventions.  Ideally, quantitative standardized minimum 
inhibitory concentration methods should be applied. 
 
Precautionary bans on growth promotants have been established in Sweden 
(1986) and the European Union (1997).  These bans had roots in recommendations dating 
back to 1969 with the Joint Committee on the use of Antibiotics in Animal Husbandry 
and Veterinary Medicine in the United Kingdom which concluded that “the 
administration of antibiotics to farm livestock, particularly at sub-therapeutic levels, 
poses certain hazards to human and animal health; in particular it has led to resistance in 
enteric bacteria of animal origin.”  Since these bans, conflicting reports of success and 
failure as a result of the bans have been reported.  The occurrence of antimicrobial 
resistance in a national population of food animals was ultimately reduced after the 
government of Denmark banned avoparcin in 1995 and virgniamycin 1998 (Aarestrup et 
al. 2001).  However, a list of adverse consequences such as a deterioration of animal 
health and an increase in the usage of therapeutic antibiotics in food animals which are of 
direct importance to human medicine has also been reported (Casewell et al. 2003; 
Bywater 2005).  A separate study in Switzerland reports that the ban on growth 
promotants in feedstuffs did not result in an increase in therapeutic use of antibiotics in 
medicated feed (Arnold et al. 2004).  Additionally, long-term evaluation of the bans in 
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swine showed an improvement in productivity (Aarestrup et al. 2010).  A report 
investigating the possibility of a similar ban in the United States has stated that 
discontinuing use of antimicrobial drugs in swine production would initially decrease 
feed efficiency, raise feed costs, reduce production, and raise prices to consumers 
(Matthews 2001).     
Prudent and judicious use of antimicrobial drugs has been suggested as a means to 
reduce consumption and manage resistance in both human and veterinary medicine 
(Shlaes et al. 1997; Morley et al. 2005).  In Germany, the change in prescription patterns 
of veterinarians in response to prudent use guidelines dramatically reduced antimicrobial 
drug consumption within 2 years (Ungemach et al. 2006).  Antibiotic stewardship and 
consumption varies across European human hospitals, but studies are currently underway 
to evaluate the impact of prudent use guidelines including optimal approaches to 
respiratory infections, cycling antimicrobials in intensive care units, patient education 
materials, and strategies to improve doctor-patient communication (Bruce et al. 2004; 
McGowan 2000; Schwartz 1999).  The FDA-CVM has recently distributed a draft 
guidance for the judicious use of medically important antimicrobial drugs in food-
producing animals (2010) which puts forth two measures to phase in:  
1. Limiting medically important antimicrobial drugs to uses in food-producing 
animals that are considered necessary for assuring animal health; and  
 
2. Limiting such drugs to uses in food-producing animals that include veterinary 
oversight or consultation. 
 
In addition to prudent use, improved infection control and hygiene have been suggested 
to further reduce consumption of antimicrobial drugs (van den Bogaard and Stobberingh 
1999).  These efforts together may have the ability to “turn the tide of antimicrobial 
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resistance” (Monnet and Kristinsson 2008).  Yet, expectations of reversals in 
antimicrobial resistance should be accepted with caution since adequate data are lacking 





CHALLENGES IN ANTIMICROBIAL RESISTANCE SURVEILLANCE 
 
 The burden of antimicrobial resistance has both health and economic impacts and 
efforts to reduce these are warranted (Holmberg et al. 1987; Howard et al. 2001; Howard 
and Scott 2005; McGowan 2001).  Improved surveillance systems which investigate 
associations between use and resistance can serve as “information for action” in 
developing policies which reduce unnecessary prescribing and prolong the usefulness of 
antibiotics (Livermore 1998).  Minimum epidemiological and microbiological 
requirements for establishing surveillance of antimicrobial resistance in bacteria of 
animal origin have been defined (Caprioli et al. 2000).  However, the intricacies of 
surveillance components are not well understood.  This chapter has described issues 
surrounding antimicrobial resistance, surveillance efforts currently in place, the 
prevalence of antimicrobial resistance in feedlot cattle, indirect and direct associations 
between antimicrobial resistance and use, the necessity of antimicrobial use in feedlot 
cattle, and the regulatory policies surrounding these issues.  Some areas to consider 
which represent gaps in knowledge about antimicrobial use and resistance are listed 
below. 
 
Summary of Gaps (bold indicates gaps being further considered in this 
dissertation): 
 




 Ecological approaches to evaluation of microbial relationships between humans and 
animals 
 Accurate quantification of antimicrobial use 
 Investigations of the dissemination and persistence of antimicrobial resistance 
 Comprehensive risk assessments of antimicrobial resistance 
 More antimicrobial resistance surveillance programs; local, national, and international 
 Optimization of methodology and standardization for surveillance programs 
 Susceptibility testing capable of detecting novel resistance 
 Prevalence of resistance in food-producing animals 
 Studies investigating direct associations between antimicrobial use and 
resistance 
 Identification of other factors inflating or hiding true associations  
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 In the investigation of antimicrobial resistance, antimicrobial use must be 
accurately quantified since it is hypothesized to be one of the major forces driving the 
development of resistance.  Without accurate representation of exposures to 
antimicrobials, the association between antimicrobial use and resistance can be falsely 
inflated or hidden.  The selective pressures which encourage the development, 
dissemination, and persistence of antimicrobial resistance vary by a number of factors 
including the antimicrobial drug and the degree of exposure in host tissues to 
heterogeneous populations of bacteria.  Yet, the common metrics (sales value and mass 
of active ingredient) currently used to quantify antimicrobial use do not account for the 
selective pressures in any manner.   
 The following project investigates the appropriateness of a series of metrics for 
quantifying antimicrobial use in beef feedlots.  Individuals knowledgeable and interested 
in this particular topic contributed their perceptions about the related issues in a web-
based survey.  Participants were prompted to indicate the accuracy of each metric to 
describe antimicrobial use as well as the clarity of each metric in reference to how easily 
it is understood by user groups.  These responses help to validate portions of the 
methodologies recommended for analysis and reporting of antimicrobial use information 






Objectives: In order to further enlighten discussions regarding the impact of antimicrobial 
drug use in agriculture, accurate antimicrobial drug use data are needed.  The primary 
objective of this study was to investigate the preferences of stakeholders for reporting 
antimicrobial drug use data that are collected from beef feedlots.   
 
Materials and Methods: Producers, veterinarians, industry representatives, public health 
officials, and other knowledgeable beef industry leaders were invited to complete a web-
based survey.  Participants were asked to provide demographic information and to 
comment on the most appropriate portrayal of antimicrobial drug use data for different 
purposes.  The survey also explored perceptions and concerns about antimicrobial 
resistance.   
 
Results: A total of 156 participants in 33 U.S. states, 4 Canadian provinces, and 8 other 
countries completed the online survey.  Preference for methods of presenting 
antimicrobial drug use data varied and was influenced by participant perceptions 
regarding clarity and accuracy of the method to represent antimicrobial drug use in large 
cattle populations.  Antimicrobial drug use has most commonly been reported as mass of 
active compound or sales value; however, participants in this study indicated that these 
methods were the least appropriate for reporting data to the general public.  Compared to 
10 years ago, many participants had greater concern about antimicrobial resistance as a 
health issue for both humans and animals.  
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Conclusions: To effectively communicate antimicrobial drug use data, evaluation of the 
target audience is critical to presenting the information clearly and accurately.  Metrics 






Antimicrobial drugs (AMDs) are used in the feedlot for prevention of disease 
(prophylaxis/metaphylaxis), treatment of disease and improvement of production 
efficiency (Apley 1997; Apley 2008; Barton 2000).  Due to concerns about the potential 
impact on public health and the development of antimicrobial resistance (AMR), 
antimicrobial drug use (AMU) in cattle and other animals is a controversial subject 
(Barbosa et al. 2000; Casewell et al. 2003; Phillips et al. 2004; van den Bogaard et al. 
2000; Witte 1998). 
Obtaining accurate data about AMU is critical to improving our understanding of 
the controversial public health and AMR issues (Caprioli et al. 2000; McEwen and Singer 
2006; Phillips 1998; van den Bogaard et al. 1999; FAAIR Scientific Advisory Panel 
2002; Livermore et al. 1998).  In order to report accurate usage and investigate potential 
associations with AMR, we need accurate and practically relevant measures to 
objectively quantify AMU (Carson et al. 2008; Filius et al. 2005; Singer et al. 2006).  
Metrics which have been and are still being used are defined (Table 1).  Each of these 
methods of reporting drug usage has both advantages and disadvantages (Chauvin et al. 
2001; Jensen et al. 2004; Merlo et al. 1996; Kritsotakis 2006).  The goal of this survey 
was to identify a method for presenting AMU data that is easily understood by user 






Table 1:  Definitions of antimicrobial drug use (AMU) metrics. 
AMU Metric Definition 
  
Sales Value cost of the antimicrobial drug in standard 
currency 
  
Drug Mass in Kilograms kg of active ingredient  
  
Number of Animals Treated count of animals treated with antimicrobial drug 
  
Treatment Rate the percentage of animals receiving a given 
treatment in a given population 
  
Animal Defined Daily Dose (ADDD) number of days of treatment for an animal based 
on an assumed average maintenance dosage 
  
ADDD per 1000 Animals  standardized exposure rate based upon the 
Animal Defined Daily Dose relative to a fixed 
number of animals; used to make standardized 
comparisons in drug exposure among 





MATERIALS AND METHODS 
Sampling Procedures  
The study was conducted as a cross-sectional survey.  The targeted study 
population consisted of owners and operators of beef production facilities, veterinarians, 
beef industry representatives, and public health officials familiar with AMU in the beef 
industry.  Potential participants were contacted through email listservs managed by 
relevant professional associations or agenciesa and by email sent to a list of individuals 
compiled through recommendations of beef industry and public health leaders.  
Additionally, participants were encouraged to freely distribute the survey to other 
knowledgeable and interested colleagues.   
For each association or agency that was identified as being interested in this issue, 
the association president or another administrative leader was contacted by e-mail to 
determine whether their group was willing to participate.  If so, an invitation was posted 
to the association’s listserv.  This same invitation was also sent to people specifically 
identified by stakeholders as being knowledgeable and interested in the topic.  Direct 
access to the web-based survey instrumentb was provided in the email invitation as a 
hyperlink.  Additionally, this email invitation included a second hyperlink which allowed 
the invited participant to specifically decline the opportunity to participate (Appendix 2).  
Approximately 2-3 weeks after the initial invitation, a reminder email was sent through 
each listserv and to the list of individuals.  The web-based survey was available for 
completion for a 3-month period between June and August 2009.  The survey collection 
instrument was set to only allow one response to be submitted per computer. 
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Study participation was voluntary and anonymous.  Response information and 
participation was confidential.  Prior to initiation of the study, the research protocol was 
reviewed and approved by the Colorado State University Institutional Review Board.   
 
Survey instrument  
The survey contained 22 questions characterizing 3 different general topics: 
participants’ demographics and activities related to the beef industry, opinions on the 
issues of AMU and AMR, and perceptions about how information regarding AMU is best 
reported for beef cattle (Appendix 1).  Most of the questions required participants to 
select from a closed series of responses or Likert scale categories.  For all questions, 
response options of “Unknown” and “No Preference” were available.  Additionally, 
open-ended responses were solicited on some questions to allow elaboration if desired by 
the participant.  The questionnaire was pretested by 9 experts that matched the 
demographics of the intended study population.  
Demographics.  Individual participants were characterized through questions 
regarding the number of years of active involvement with the beef industry, the primary 
state/province and nation of their professional activities, and their highest level of 
education (high school diploma/GED, degree/diploma from a technical school or 
community college, bachelor’s degree/BS/BA, advanced degree—specify).  Additionally, 
participants were characterized by the primary professional role in which they used AMU 
information (producer, production consultant, veterinarian, federal government 
representative, state government representative, university employee, nutritionist, feed 
salesperson, pharmaceutical industry representative, other—specify) and the top three 
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sources from which they obtain information about AMDs (feed or drug companies, 
veterinarians, government extension officers, universities, farm magazines and 
newsletters, friends/relatives/neighbors, internet/world wide web, peer reviewed journals, 
beef specialists, other—specify).    
Perceptions about AMR and AMU.  Regarding AMR as a health issue, 
participants were asked whether their concerns had changed over the 10 years prior to the 
study (much greater, somewhat greater, no different, somewhat less, much less) at 
different organizational scales (locally/individual operations, regionally, nationally, 
globally).  Similarly, participants provided their perceptions on the true risk of health 
problems as a result of AMR.  Participant perceptions regarding the importance of five 
uses of AMDs in feedlot cattle were also solicited.  This was achieved through providing 
categories that specified the necessity of AMDs for each use (feedlots need AMDs for 
this specific use, feedlots would be difficult to manage without this specific use, feedlots 
could be managed without this specific use, feedlots do not need AMDs for this specific 
use).  The five uses of AMDs investigated were prophylaxis/metaphylaxis at arrival, 
prophylaxis/metaphylaxis after arrival, use in feed or water for treatment of disease, 
injectable drugs for treatment of disease, and use in feed to prevent liver abscesses.  
AMU Metrics.  In order to investigate the appropriateness of different methods of 
quantifying AMU for various purposes, participants were asked to select the first and 
second most appropriate methods (which are reported cumulatively) of quantifying AMU 
relative to hypothetical scenarios.  Scenarios included a comparison AMU for 2 AMDs in 
a large cattle population (e.g., feedlot), describing AMU data for investigation of AMR in 
a scientific paper, and reporting of AMU data to the general public.  Participants were 
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also asked to identify the least appropriate quantification method for reporting AMU to 
the general public.  The scenarios were all structured around hypothetical situations 
which summarized the use of 2 AMDs according to label instructions for respiratory 
disease in an ‘average’ population of feedlot steers shortly after placement.  An average 
steer was considered to weigh approximately 250kg.  Quantification methods were 
presented in tabular form with analogous calculations between the two hypothetical 
AMDs.  The quantification methods investigated in this survey were number of treated 
animals, total mass of active drug, Animal Defined Daily Dose (ADDD), ADDD per 
1000 animals, treatment rate, and sales value (Table 1).  Definitions of each method were 
provided in each relevant section of the survey to ensure that participants were able to 
appropriately distinguish the different metrics (Appendix 1).  
In the context of summarizing AMU for large cattle populations, participants 
specified the clarity and accuracy for two of the investigated metrics, number of animals 
treated and ADDD per 1000 animals (clarity categories: very clear, clear, somewhat 
clear, not clear, unknown; accuracy categories: very accurate, accurate, somewhat 
accurate, not accurate, unknown).  In reference to an ongoing prospective surveillance 
program, participants were asked to select the best method for summarizing AMU for 
different organizational scales (local/individual operations, regional, national, global) and 
if a different definition or measurement was more appropriate for surveillance programs 
than the ones provided in this survey (unknown, no, yes—specify).   
In regards to use of the ADDD method, participants were asked if data should be 
1) calculated separately and reported separately for high and low dose exposures of the 
same drug, 2) calculated separately for high and low dose exposures, summed and 
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reported as one summary number, or 3) calculated using a common dose regardless of 
exposure and reported together.  An open-response question asked participants to 
interpret “400 ADDD of tetracycline.”  The definition of ADDD was available on the 
same page as this open-response question.   
Since AMD dosages can differ for various intended uses (e.g., prophylaxis, 
metaphylaxis, treatment of clinical disease, or improvement of production efficiency), 
participants were asked whether it was appropriate to combine these four categories when 
summarizing AMU data (yes, no, unknown, it depends—specify).  A similar question 
asked if combining AMU data across different classes of AMDs would be appropriate 
(yes, no, unknown, it depends—specify).   
 
Data analysis 
Survey responses were downloaded directly from the web-based collection 
instrument into a computer spreadsheet and summarized.  Odds ratios with associated 
95% CIs were calculated for contingency tables and the χ2 test was performed with 
statistical software.c  For the purposes of analysis, some response categories were 
collapsed to facilitate evaluation of simple associations.   
Demographic Classification for Categorical Analysis. The responses for the 
number of years of active involvement in the beef industry were dichotomized as being < 
or ≥ the median of the response distribution.  Participant locale was categorized into 
North American (U.S. and Canada), and non-North American.  Professional role was 
categorized as veterinarian, university employee, producer, and other.  The preferred 
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sources of AMD information were categorized as peer reviewed journal, veterinarians, 
feed or drug companies, and others.   
Categorical Analyses of opinions about AMR and AMU Metric Classification.  In 
order to facilitate analyses, Likert scale responses were dichotomized into categories for 
greater (much greater and somewhat greater) and not greater (no difference, somewhat 
less, much less, and unknown).  Quantification metrics were grouped into three 
categories: 1) ADDD or ADDD per 1000 animals, 2) number of animals treated or 
treatment rate, and 3) sales value or total mass of active ingredient.  Responses of 
unknown and no preference about appropriate metrics were excluded from analysis due 
to low response frequency for these categories.  Responses to questions regarding the 
clarity and accuracy of ADDD per 1000 animals and number of animals treated were 
dichotomized into clear/accurate (very clear/accurate, clear/accurate) and not 
clear/accurate (somewhat clear/accurate, and not clear/accurate).  A single evaluator 
(KMB) categorized the open-response question for defining “400 ADDD of tetracycline.”  
Responses which indicated participant understanding of the definition of ADDD were 
considered correct.  Other responses were designated as incorrect if an obvious 
misunderstanding was described in open-response or as unknown if the participant 





Twenty associations and agencies were identified as having goals or interests that 
would be relevant to the issue of AMU in cattle.a  Administrative leaders from 10 
organizations agreed to post the invitation to their listservs and an additional 6 
associations or agencies provided a list of specific individuals to contact directly with an 
invitation to participate.  The survey was initiated by 250 individuals and 156 of these 
participants fully completed the survey.  Only responses from completed surveys were 
summarized.  Ninety-eight individuals specifically declined to take the survey using the 
hyperlink that was included for this purpose (Appendix 2).   
 Respondents resided in 33 U.S. states, 4 Canadian provinces, and 8 other 
countries (Belgium, Denmark, Germany, Ireland, Italy, Portugal, South Africa, and 
United Kingdom).  The majority of respondents were from the U.S. (81%; 124/154) and 
Canada (12%; 19/154).  The median number of years of reported involvement in the beef 
industry was 20 (Q1=10, Q3=34).  Veterinarians (51%; 79/156), university professionals 
(19%; 29/156), and producers (10%; 16/156) were the professional roles most commonly 
represented by the participants.  Other participants reported their professional roles as 
pharmaceutical industry representatives (8%; 13/156), federal government representatives 
(5%; 8/156), feed sales representatives (1%; 2/156), state government representatives 
(0.6%; 1/156), production consultants (0.6%; 1/156), or other (4%; 7/156).  As their 
highest earned degree, 90% (140/156) of participants held advanced degrees (e.g., MS, 
PhD, DVM), 6% (10/156) had baccalaureate degrees, 1% (2/156) had degrees from a 
technical school or community college, and 3% (4/156) had high school diplomas/GEDs.   
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Sources of Information.  Seventy-two percent (112/156) of participants used peer-
reviewed journals as one of the top three sources of information about AMDs, 60% 
(93/156) obtained information from veterinarians, 59% (92/156) gained their knowledge 
from feed or drug companies, and 37% (58/156) referenced universities.  The world wide 
web (29%; 46/156) was used more often as one of the top three sources of AMD 
information than beef specialists (13%; 20/156), government extension officers (5%; 
8/156), and farm magazines or newsletters (5%; 8/156). 
 
Importance of Antimicrobial Drug Resistance 
   The study attempted to differentiate perceptions about differences in awareness or 
perceived risk from differences in true risks related to AMR.  In general, participants had 
greater concern about AMR as either a human health issue or an animal health issue than 
they did 10 years prior to the study (Figure 1).  Compared to their attitudes 10 years ago, 
61% (95/156) of participants indicated that they had a much greater or somewhat greater 
concern about AMR as a global health issue for people.  Similarly, about half (78/156) of 
the participants indicated that they had a greater or somewhat greater concern about 
AMR as a global health issue for animals.  Participant concerns about AMR as a global 
health issue for people were no different than concerns about AMR as a global health 
issue for animals (P=0.17).  When comparing responses regarding AMR as a global 
health issue for people to other scales, no differences were found at the national level 
(P=0.77).  However, fewer participants had greater concern about AMR as a local (41%; 
64/156; P=0.0032) and regional (49%; 76/156; P=0.027) health issue for people than at 
the global level.  No differences were detected between responses about concern 
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expressed regarding AMR in animals at the global scale when compared to the local 
(P=0.76), regional (P=0.88), or national (P=0.81) scales. 
 
 
Figure 1: Change in participants’ level of concern about antimicrobial resistance 
(AMR) as a global health issue in people and animals during the previous decade 
(n=156).*Distributions of participant perception of greater or less true risk of health 
problems due to AMR in people and in animals compared to their perception of true risk 
10 years prior the study were no different than the distribution of concern level for 
Animals presented here (P>0.05). 
 
Despite the majority of participants having greater concern about AMR as a 
global human health issue, fewer participants believed that the true risk of global human 
health problems as a result of AMR was greater than 10 years prior to the study (41%; 
64/156; P=0.006).  The percentage of participants with increased perceptions of true risk 
in animal health due to AMR was not statistically different than that for humans (45%; 
70/156P=0.33).  Compared to the global level, perceptions of true risk of human health 
problems due to AMR on the local (P=0.20), regional (P=0.17), and national (P=0.64) 
0% 20% 40% 60% 80% 100%
People
Animals
Participants with a Difference in Concern about AMR as a Health Issue
Greater No Difference Less Don't Know
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scales were not statistically different.  Likewise, the true risk of animal health problems 
as a result of AMR were not statistically different on the local (P=0.74), regional 
(P=0.51), and national (P=0.77) scales when compared to the global level.   
Importance of Antimicrobial Drug Use 
   Participants indicated a similar spread of opinions on the necessity of AMDs for 
prophylaxis/metaphylaxis at arrival, prophylaxis/metaphylaxis after arrival, use in feed or 
water for treatment of disease, and use in feed to prevent liver abscesses (Figure 2).  Four 
to 11% (6/156 – 17/156) of participants indicated that AMDs are not needed for these 
uses.  Overall, about 20% of participants (16% - 22%; 25/156 - 34/156) indicated that 
AMDs are required for these uses. Whereas about one third of participants indicated that 
feedlots could be managed without AMDs (31% - 37%; 48/156 - 58/156) or management 
would be difficult without AMDs (30% - 42%; 47/156 - 65/156) for these uses.  In 
contrast, the majority of participants agreed that injectable AMDs were needed for 
treatment of diseases of feedlot cattle (87%; 136/156).  The remaining 13% (20/156) of 
participants indicated that management would be difficult without injectable AMDs for 







 Comparing 2 different classes of AMDs (e.g. macrolides vs. tetracycline).  When 
comparing amounts of two different classes of AMDs, a similar percentage of 
participants indicated that the total mass of active drug (43%; 67/156) and the ADDD per 
1000 animals (41%; 64/156) metrics were most useful (Figure 3).  The sales value (11%; 
17/156) metric was selected least often as an appropriate metric for comparing 2 different 
classes of AMDs.   
 Describing AMU relative to AMR in a scientific paper.  When describing AMU 
data relative to investigating AMR in a scientific paper, ADDD per 1000 animals was the 
metric selected by the 46% of participants as most useful (72/156) (Figure 3).  Sales 
value (2%; 3/156) and total mass of active drug (31%; 48/156) were selected by even 
fewer participants as appropriate metrics for this purpose than in the previous scenario.   
 Reporting AMU data to the public.  More than half of the participants selected 
treatment rate (55%; 86/156) as the method which would allow the clearest interpretation 
in reporting data regarding AMU to the general public (Figure 3).  As with the two 
previous scenarios, sales value (8%; 12/156) was selected by the smallest percentage of 
participants as an appropriate metric for reporting AMU data to the public.  When asked 
about the least appropriate metric (as opposed to the most appropriate metric), 
respondents indicated that sales value (44%; 69/156) and total mass of active drug (31%; 
49/156) were the most inappropriate metrics for reporting AMU data to the general 
public.  All other metrics for this question were each selected by less than 8% (12/156) of 




Figure 3: Participant selection of the top two antimicrobial drug use (AMU) 
metrics (cumulatively presented) most appropriate for three separate scenarios; 1) when 
comparing the amount of two hypothetical drugs in a large cattle population (hatched), 2) 
when describing AMU data relative to antimicrobial resistance (AMR) in a scientific 
paper (black), 3) when clearly reporting data regarding AMU to the general public (gray) 
(n=156).* Categories available for participant selection not displayed in this figure 
include Unknown, and No Preference. 
 
 Summarizing large-scale surveillance.  Quantifying AMU as the number of 
animals treated was judged as the clearest metric for representing AMU when reporting 
this information for large cattle populations. Quantifying AMU by ADDD per 1000 
animals was deemed the most accurate metric for representing AMU for large-scale 
surveillance of AMU and AMR.  The majority (88%; 137/156) of the respondents 
specified that number of animals treated was clearly understood, but only 36% (56/156) 
specified that it was accurate.  Conversely, only 32% (50/156) of respondents specified 
that the ADDD per 1000 animals method was clearly understood, while 76% (119/156) 



















































 Approximately half of the participants selected ADDD per 1000 animals as the 
best method of summarizing AMU for prospective surveillance programs at the 
state/provincial (51%; 79/156), national (53%; 83/156), and global (50%; 78/156) 
organizational scales.  All other metrics were selected by less than 15% (24/156) of 
participants for these purposes.  Specifically, sales value was selected by less than 3% 
(5/156) of participants as the best method for summarizing AMU.  For surveillance 
programs, most participants (74%; 116/156) were unaware of a more appropriate 
definition or measurement than the ones investigated in this survey.  Participants who 
indicated that a different definition or measurement was more appropriate than the ones 
provided in the questionnaire commented on refining specific definitions and stratifying 
metric summaries according to different confounders. 
Utilizing the ADDD metric.  Participants indicated that the usage of the ADDD or 
ADDD per 1000 animals requires specific and clear definitions.  Most participants (74%; 
116/156) recommended the separate calculation of high and low dose exposures of the 
same drug and subsequent separate reporting of these amounts.  Less than 10% of 
participants (14/156) held the opposing views of calculating ADDDs in some variant of 
averaging dosages.  In a free-response, 64% (98/153) of participants correctly interpreted 
“400 ADDD of tetracycline” while 20% (31/153) incorrectly did so and 16% (24/153) 
indicated upfront that they did not know how to interpret the phrase.   
Summarizing Metrics. In the reporting of any AMU metric, most participants 
believed that separately reporting amounts by the intended use of the AMDs and the class 
of AMDs is critical to accurately portraying AMU information.  Summarizing quantities 
for the combined uses of prophylaxis, metaphylaxis, treatment of clinical disease, and 
 
 59
improvement of production efficiency was not considered an accurate representation by 
67% (105/156) of participants.  Only 9% (14/156) considered the combination of these 
uses in reporting as an appropriate summarization.  Another 22% (34/156) of participants 
indicated that the accuracy of such a summary measure would depend on other factors 
beyond just these categories such as the purpose of collecting the data, how the data were 
collected, and the particular AMD or class of AMD.  Combining AMU information 
across different classes of AMDs was also considered inappropriate by 60% (94/156) of 
participants.  Some participants (13%; 21/156) specified that the accuracy of AMU data 
which combined different classes of AMDs would depend on the reporting situation. 
 
Response Associations 
Participants with ≥20 years of beef industry involvement were half as likely 
(OR=0.5, 95%CI: 0.2-0.9, P=0.02) to have increased concern about AMR today as a 
global human health issue compared to 10 years prior to the study when compared with 
participants with <20 years of beef industry involvement.  These experienced participants 
were also more likely than the participants with <20 years to believe that AMU in feed or 
water for treatment of disease was not needed rather than needed in the management of 
feedlots (OR=11.3, 95%CI: 2.4-., P=0.01).  When comparing two different classes of 
AMDs (OR=2.6, 95%CI: 1.2-5.5, P=0.01) or describing AMU data relative to AMR 
(OR=2.6, 95%CI: 1.2-5.9, P=0.02), participants with ≥20 years of beef industry 
involvement were more likely to select a method other than ADDD and ADDD per 1000 
animals than participants with <20 years of involvement.    
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In comparison to North American participants, non-North American participants 
had different perspectives on the health risks of AMR, the necessity of AMDs in the 
management of feedlots, and appropriate AMU metrics.  Participants from non-North 
American countries were more likely to believe that the true risk of health problems in 
people (OR=5.2, 95%CI: 1.4-19.0, P=0.01) and animals (OR=4.0, 95%CI: 1.1-14.7, 
P=0.03) because of AMR as compared to 10 years ago was greater on the global scale.  
Non-North American participants were more likely than North American participants to 
indicate that AMDs are not needed rather than needed for the typical uses in North 
American feedlots of prophylaxis/metaphylaxis at arrival (OR=32.0, 95%CI: 4.0-264.3, 
P<0.001) and in feed for prevention of liver abscesses (OR=5.5, 95%CI: 1.0-28.8, 
P=0.05).   When asked about the best metric, non-North American participants were 
more likely than North American participants to select ADDD or ADDD per 1000 
animals as appropriate for the scenarios of comparing two different AMDs (P=0.01) and 
for reporting data regarding AMU to the public (P=0.01). 
 Both professional role and highest degree earned influenced participant responses.  
Participants with professional roles in universities were more likely than veterinarians to 
believe that the true risk of AMR as a health issue to people is greater than 10 years prior 
to the study on the regional (OR=5.6, 95%CI: 2.3-13.9, P<0.001), national (OR=3.5, 
95%CI: 1.4-8.3, P<0.001), and global (OR=3.2, 95%CI: 1.3-7.5, P=0.01) scales.  When 
describing AMU data relative to AMR data, producers were more likely than participants 
from other professional roles to select metrics considered inappropriate by most survey 
respondents (sales value and total mass of active drug) (P=0.03).  In a related manner, 
participants with advanced degrees were more likely than participants with a bachelors 
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(P=0.05) or high school diploma (P=0.05) to select ADDD or ADDD per 1000 animals 
as the most appropriate measure for the same scenario.  Additionally, participants with 
advanced degrees were more likely to indicate that combining information across 






Results of the present study suggested that there is no single, best method to 
appropriately represent AMU data related to beef cattle production.  To effectively 
communicate AMU data, evaluation of the target audience is critical to clearly presenting 
the information.  Metrics that are most accurate may need to be carefully and repeatedly 
explained to the audience.  In the past, reports of AMU that focused on sales value or 
mass of active ingredient metrics as estimates of AMU have not allowed for appropriate 
investigation of associations between AMU and AMR.  Theoretically, differences in the 
physical characteristics of AMDs, the doses, the dosages, numbers of animals treated, and 
the reasons for use all modify the effect that AMU has on AMR.  Metrics relying on sales 
value or mass of active ingredient do not account for these differences.  Incorporating 
such selection pressures in AMU metrics is crucial to understanding the development, 
persistence, and dissemination of AMR within and between populations of animals and 
humans.  Quantification of AMU with metrics which does not account for selection 
pressures distorts discussion regarding the impact of AMU and cannot be used to 
investigate AMR. 
Data regarding AMU is presented in a variety of formats depending on the 
purpose of reporting and the intended audiences.  Some surveillance programs have 
quantified specific use of AMDs with a direct focus of investigating the impact of AMU 
on AMR.  This work can be performed on a small scale, such as within a single facility or 
on a grander scale, such as on a national level (Dunowska et al. 2006; Bager 2000; 
Bergman 2009; Bunner 2007).  With data specifically and accurately gathered, 
researchers can evaluate associations or lack of associations between AMU and AMR.  In 
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contrast, other reports have summarized various estimates of the quantity of AMDs used 
to illustrate discrepancies in use between humans and animals or between reasons for 
AMU (Institute of Medicine 1989; Mellon 2001).  These latter reports commonly present 
AMU information in terms of mass of active ingredient or sales value of the AMDs.   
AMU in humans and animals creates a selection pressure that contributes to a 
local increase in AMR.  In theory, bacteria susceptible to the AMD are eliminated and 
resistant bacteria in the previously heterogeneous bacterial population persist (Levy et al. 
2004).  However, the probability of occurrence of this phenomenon in association with 
AMU and the strength of this association is unknown.  Additionally, little is understood 
about the duration of persistence within populations of animals and humans as well as 
about the likelihood of transmission of resistance between populations (Singer et al. 
2007).  To better elucidate the existence of human and animal health risks as well as the 
burden of such risks associated with AMU, a proper quantification and reporting metric is 
needed (Menendez Gonzalez et al. 2010; Carson et al. 2008).  
Choosing an appropriate metric for reporting data regarding AMU is a 
deceptively complex matter.  Challenges in the accuracy and clarity of reporting AMU 
vary by the AMD of concern and the organizational scale of reporting (e.g., comparisons 
between farms vs. comparisons between regions or countries).  AMDs are provided by 
pharmaceutical companies in different combinations of ingredients and are administered 
by different routes and dosing schedules (Ferarro et al. 2001; McEwan et al., 2002; 
Bywater 2004; Khachatourians 1998; Parveen et al. 2006; Rifenburg et al. 1996).  
Selection pressures against target bacteria are analogous between the formulations of the 
same AMD or between similarly structured AMDs (same class of drug) or both (Bywater 
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2004; Wang et al. 2006).  However, even the exact same formulation of a drug (e.g. 
tetracycline) can apply selection pressures differently.  For example, a “High Dose” 
situation to treat disease could apply a stronger pressure to a population of bacteria and 
eliminate bacteria with marginal susceptibility to the AMD.  Yet, a “Low Dose” of the 
same AMD to improve production efficiency may lead to the quicker development of 
AMR since the marginally susceptible and the resistant bacteria would survive and 
comingle resistance traits (Craig 2001, Funk et al. 2006; Ghosh and LaPara 2007; 
Guillemot et al.1998; Kohanski et al. 2010).  
The web-based format of this study was an easy and quick method to solicit the 
opinions of a variety of people that are affected by policy decisions regarding AMU in 
cattle.  However, there are limitations that must be considered when interpreting these 
results.  Conducting an extensive survey utilizing probability based sampling strategies 
was not possible since the total population (sampling frame) of experts in beef cattle 
AMU and AMR was unknown.  With no prior knowledge of the sampling frame, a 
convenience sample was considered the best method to quickly and easily obtain a 
reasonably wide distribution of the questionnaire to individuals that were knowledgeable 
and interested in the topic.  Therefore, the representativeness of the sampled individuals 
to the theoretical target population of experts in beef industry AMU and reporting could 
not be validated.  However, the associations, agencies, and individuals targeted by 
invitation to the questionnaire were all recognized as important stakeholders. 
Though this survey may not have included or represented all experts in the beef 
industry, stakeholders with advanced degrees were well represented.  Likely, holding an 
advanced degree would aid an individual in evaluating appropriate AMU metrics since 
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the complexities of the related issues are not directly intuitive.  However, the ADDD or 
ADDD per 1000 animals metrics were not clearly definable by all of the highly educated 
respondents to this survey.  The lack of participants’ knowledge about the ADDD metrics 
may have contributed to nondifferential misclassification when selecting useful metrics.  
These participants might have been drawn towards or away from selecting ADDD 
metrics if they were unable to distinguish them from other metrics or if they ignored 
metrics they did not understand, respectively.  Additionally, stakeholders that were 
willing to participate may not have submitted a complete survey (thus, not included in 
this report) if they were not comfortable with their grasp on the intricacies of the ADDD 
metrics.  If stakeholder groups which were not well represented in this study were 
included, different distributions of responses might be expected.   
This study investigated a finite number of quantification methods which represent 
categories of a large number of metrics that have been used.  The ones used in the study 
were chosen to encompass the metrics most commonly used (sales value and total mass 
of active ingredient) and those which more fully account for selection pressure (ADDD 
and ADDD per 1000 animals).  Since more than one metric may be viewed as appropriate 
in a specific situation, we solicited responses which allowed for the top two choices.  The 
results have been presented here as a cumulative percentage of the top two choices 
because the interval perceived by the participant between their two choices can vary.  
Depending on the purpose of the research, how the data were collected, the organism 
being investigated for AMR, and the AMDs of interest, other metrics could be 
appropriate.  However, in every case the concepts of clarity and accuracy of reporting 
should always be highly regarded.   
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Accuracy and clarity together are hard to come by in quantifying AMU.  If we 
describe AMU to the absolute detail of what it represents, often we lose the simplicity of 
the representation.  Participants indicated that though ADDD metrics lack clarity, they 
are quite accurate as opposed to the clearly understood metric, number of animals treated, 
which lacks accuracy.  Participants of this study indicated the superior accuracy of the 
ADDD metric, yet not all participants were able to correctly define an ADDD metric.  
Therefore, though the details behind this metric may not be wholly understood, 
participants were still able to recognize that this metric better represents AMU than the 
other metrics.   The absence of a complete understanding of ADDD does not invalidate 
audience ability to interpret reports.  
In designing the questionnaire, AMU in the feedlot setting was the primary focus.  
AMU and AMR data in North American feedlots has not been available in the past and 
current efforts to develop an appropriate surveillance system in Canada are underway.  
Therefore, our research group was specifically interested in the responses of stakeholders 
in the feedlot industry.   Other animal production industries such as swine, poultry, or 
dairy operations may utilize AMDs differently, but types of use are generally similar.  
Other animal agribusinesses with scenarios which are not analogous to the feedlot 
scenarios presented would need further investigation since we did find that the 
appropriate metric depends on the user audience of the information and the research 
question.  Ideally, a common method or pairing of methods would be used in all animal 





aAssociations and agencies that were contacted to solicit their participation included the 
Academy of Veterinary Consultants, the American Association of Bovine Practitioners, 
the American College of Veterinary Clinical Pharmacology, the American College of 
Veterinary Preventive Medicine, the American College of Veterinary Internal Medicine, 
the American Public Health Association, the Association of State and Territorial Health 
Officials, the Association for Veterinary Epidemiology and Preventive Medicine, 
Canadian Cattlemen’s Association, the Centers for Disease Control and Prevention, the 
Council of State and Territorial Epidemiologists, the EPIVET listserv, the United States 
Food and Drug Administration, Feedlot Health Management Services, the International 
Conference on the Use of Antimicrobials in Cattle Production, the National Association 
of State Public Health Veterinarians, the National Cattlemen’s Beef Association, the 
Public Health Agency of Canada, the Texas Cattle Feeders Association, and the United 
States Department of Agriculture. 
 
bSurveyMonkey.com. Portland, Oregon USA.   
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CHAPTER 3: Evaluation of resistance classification accuracy 
by latent class analysis of data from disk diffusion and broth 
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 The resistance status of isolates representing an individual or a population is 
determined by susceptibility testing.  Surveillance programs must accurately identify and 
monitor levels of resistance in order to effectively respond to susceptibility problems or 
emerging resistance threats.  Yet, the unbiased accuracies of the common susceptibility 
testing methods (disk diffusion and broth microdilution) are unknown.  Therefore, 
resistance information from these tests might provide false impressions of the true status 
of resistance.  It is unlikely that mitigation strategies that are based on inaccurate 
information will be as useful as those based on unbiased estimates.   
 The following project investigates accuracies of disk diffusion and broth 
microdilution using a novel analysis technique.  The ability of each test to correctly 
identify resistance and non-resistance to different antimicrobial drug and organism 
combinations is determined without assuming the superiority of one test over the other.  
The dogmatic approach in developing antimicrobial resistance surveillance programs has 
been to use broth microdilution susceptibility testing over the disk diffusion method.  
However, results of this project show that disk diffusion can be an appropriate choice for 







Objective:  It is crucial to establish an appropriate understanding of error rates for 
antimicrobial susceptibility tests when working to establishing reliable estimates of 
antimicrobial drug resistance.  A degree of misclassification is expected with all 
diagnostic tests and the true state of resistance is ultimately unknown despite rigorous 
standardization of susceptibility testing methods.  Latent class analysis techniques are 
capable of modeling such uncertainty in classification for diagnostic tests.  The objective 
of this study was to estimate and compare the accuracy of the disk diffusion and broth 
microdilution methods for surveillance of antimicrobial drug resistance in feedlot cattle.   
 
Methods and Materials: Isolates of E. coli and M. haemolytica were tested for 
susceptibility to panels of antimicrobial drugs by standardized methodology for disk 
diffusion and broth microdilution.  Latent class analysis was used to determine the 
proportions of correctly identified resistant and non-resistant isolates for each 
antimicrobial susceptibility testing method.  The antimicrobial drugs compared in these 
analyses were ampicillin, ceftiofur, streptomycin, sulfisoxazole, tetracycline, and 
trimethoprim-sulfamethoxazole.   
 
Results: A total of 2,316 E. coli isolates from individual samples, 885 E. coli isolates 
from composite samples, and 783 M. haemolytica isolates were tested by both 
antimicrobial susceptibility tests.  Models for all organism and antimicrobial drug 
combinations indicated that both testing methods correctly classified non-resistance in a 
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high proportion of isolates.  However, the ability of the test to correctly classify true 
resistance varied among bacteria-drug combinations in the 2 tests.   
 
Conclusions: Non-resistance predicted by either method likely represents the true non-
resistance status in these bacterial populations, but errors can be expected more 
frequently when tests classify isolates as resistant.  Additionally, misclassification of 
resistance to different antimicrobial drugs occurs at different rates in the 2 bacterial 







As with any diagnostic test, antimicrobial susceptibility testing is subject to errors 
which lead to misclassification (Figure 1).  Procedural failures (sub-standard laboratory 
or sampling procedures), unpredictable responses due to biological variability in bacterial 
isolates, or other unrecognized (chance) sources of variability may all lead to diagnostic 
test errors (Greenwood 1981, 2000).  Optimally, we would always choose to employ a 
highly accurate test that minimizes such errors, but other test characteristics such as cost 
and availability can also influence our choice in testing methods.  For example, a test 
method with a lower, yet an acceptable level of accuracy might be chosen for 
surveillance monitoring if the cost of testing allowed for evaluation of a substantially 

































Disk diffusion and broth microdilution are antimicrobial susceptibility testing 
techniques which both provide estimates of phenotypic susceptibility to antimicrobial 
drugs based on bacterial growth in the presence of varying concentrations of the 
antimicrobial drug.  Internationally recognized and standardized methods for conducting 
these tests have been established by the Clinical and Laboratory Standards Institute 
(2008), as have interpretive criteria.  These breakpoints for susceptibility classification 
(based upon MIC for broth microdilution and zone diameter for disk diffusion) are also 
used in epidemiological surveillance, although some have suggested that different, lower 
breakpoints may be better suited for early detection of developing resistance in different 
ecological settings (Bywater et al. 2006; Simjee et al. 2007). 
The potential for errors in antimicrobial susceptibility testing is widely 
recognized.  In fact, when considering testing by broth microdilution and disk diffusion, 
results suspected as incorrect by disk diffusion are often considered to be confirmed or 
refuted by comparison to broth microdilution, an assumed “gold standard” test (Citron et 
al. 2005; Murray et al. 1982; Sautter and Denys 1987; Hubert et al. 1998; Woolfrey et al. 
1983; Shyrock et al.1996; Metzler and DeHann 1974; Klement 2005).  The inherent 
assumption when we consider a test to be a “gold standard” is that the test is perfectly 
accurate and that true classification status (e.g. resistance and non-resistance in 
susceptibility testing) is always correctly identified by the test.  However, all diagnostic 
tests, even highly regarded tests such as broth microdilution, are vulnerable to 
classification errors (Enoe 2000).  For susceptibility testing, cross-classification of two 
fallible tests such as disk diffusion and broth microdilution (Figure 1) without a reliable 
understanding of their error rates provides an imperfect understanding of the true 
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resistance and true non-resistance status of a population.  This type of reference-based 
test evaluation will always yield results that are biased to the extent that the reference test 
(“gold-standard”) does not correctly identify the true classification status of individuals, 
and the new test can never appear better than the reference test that is being used for 
cross-classification. 
Obtaining accurate antimicrobial susceptibility information for bacterial isolates is 
critical for testing of isolates in clinical settings and also for surveillance programs 
evaluating antimicrobial resistance in both commensal and pathogenic bacteria 
(Aarestrup 2004; APUA 2005; Levy and Marshall 2004; McEwen and Fedorka-Cray 
2002; Wassenaar and Silley 2008; Williams 2001).  Identifying important population 
trends of reduced susceptibility to available antimicrobial drugs in different populations 
and over time is necessary to facilitate an appropriate understanding of the complexities 
of antimicrobial resistance (Greenwood 2000; Vieira et al. 2008; Phillips 1998).  While it 
is possible to reduce the potential for errors through test selection and rigorous 
standardization of protocols, it is impossible to eliminate all errors.  In order to correctly 
interpret results generated for either clinical or surveillance purposes, the potential for 
errors in detecting resistant and susceptible isolates must be understood.  Further, even 
with imperfect susceptibility testing methods the prevalence of true resistance can be 
accurately established and monitored if the potential for erroneous classification is 
understood and accounted for (Caprioli et al. 2000; Varaldo 2002).   
In contrast to reference-based diagnostic test evaluation, newer methods of test 
evaluation have been identified which allow estimation of the true, unbiased parameters 
related to test accuracy (namely sensitivity and specificity) and prevalence of the 
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condition in question without presuming to know the true classification of individuals.  
Because these methods attempt to model classification probabilities that are hidden from 
direct observation, they are sometimes called latent class analysis.  The objective of this 
study was to estimate and compare the accuracy of the disk diffusion and broth 






MATERIALS AND METHODS 
 
Study Population— All animal handling and sampling procedures were approved prior 
to the initiation of the study by the Animal Care Committee of Feedlot Health 
Management Services (FHMS) and the Institutional Animal Care and Use Committee of 
Colorado State University.  Cattle sampled in this study were managed under typical 
conditions of feedlot production in North America.  Bacterial isolates evaluated in this 
study were collected as part of an ongoing project for the purpose of surveillance of 
antimicrobial resistance in feedlot cattle.  However, the isolates used in this study were 
purposefully selected from the entire sample set for the purpose of evaluating test 
sensitivity and specificity.  As such, results were not intended to provide estimates of 
resistance prevalence for the cattle enrolled in the study or for other populations of 
feedlot cattle. 
Cattle were enrolled from September 17, 2007 to January 16, 2010, and isolates 
included in this dataset were a convenience sample of the isolates that had been evaluated 
for antimicrobial susceptibility using both disk diffusion and broth microdilution.  To 
meet an important assumption of the analysis method, this set of isolates was stratified 
into 2 sample sets that were likely to have different resistance prevalences.  The structure 
of the collected data allowed easy classification of isolates into a population recovered 
from animals at arrival to the feedlot and a second population that were recovered from 
animals that had been managed in the feedlot environment for at least 60 days.  The 
resistance prevalences of these 2 sample sets were expected to be different since the latter 
isolates from established animals were more likely to have been exposed to antimicrobial 
drugs than the isolates from animals newly arriving at the feedlot.  The resistance 
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prevalences of these isolates were not assumed to be representative of the resistance 
prevalence of the population sampled for the surveillance project.  It is assumed that test 
accuracy (sensitivity and specificity) was constant across different populations and was 
not biased by the sampling scheme. 
  
Sampling Procedures— Pens of cattle were usually filled over several days as cattle 
arrived at the feedlot on different trucks.  Once occupancy of a pen of animals had been 
finalized and cattle had been allocated to the study, pen-level composite fecal samples 
were collected at three time points: at arrival, at > 60 days on feed (DOF) and at exit (≤ 
30 days prior to slaughter).  In brief, at each sampling time a new plastic spoon was used 
to combine feces from 20 fresh pen-floor pats into a new fecal cup (minimum 10 grams 
feces) for each composite sample.  The sample was mixed thoroughly, and approximately 
4 grams of feces from each fecal cup were then transferred into a vial containing 
modified Cary Blair transport media (Enteric Transport Medium, 15 ml, Cat#F01W, 
Dalynn Biologicals Inc., Calgary, Alberta) (Alexander et al. 2009).   
 Individual animals enrolled in the trial were sampled twice over the course of the 
study: during initial processing shortly after arrival to the feedlot and when cattle were re-
handled as part of standard feedlot protocols.  Each individual animal had two samples 
collected each time they were sampled: a nasopharyngeal swab sample and a fecal 
sample collected per rectum.  The nasopharyngeal sample was collected in the deep 
pharynx using a commercially available double guarded swab (# J273, Jorgensen 
Laboratories, Inc, Loveland, CO, USA).  A Cary Blair media tube (BBL CultureSwab™, 
CA90001-038, VWR  International, Mississauga, Ontario) was used to transport the 
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nasopharyngeal swab.  Individual fecal samples were collected per rectum using a new 
plastic palpation sleeve.  A minimum of 4 grams of feces from the rectum of each animal 
was transferred into a vial containing modified Cary Blair transport media (Enteric 
Transport Medium,15 ml, Dalynn Biologicals Inc.) (Alexander et al. 2009).     
 
Sample Transport and Data Storage— All samples were labeled with the date and the 
pen number (and the animal ID for individual animal samples), refrigerated in a chilled 
cooler and transported to the microbiology laboratory (Agriculture and Agri-Food 
Canada Lethbridge Research Station, Lethbridge, Alberta) for further processing by 
overnight courier.   
 
Laboratory Procedures—Nasopharyngeal swabs were processed immediately after 
overnight delivery to the microbiology laboratory.  Fecal samples were stored in a 4ºC 
cooler while processing of nasal swabs was completed.   
 
Nasopharyngeal Swabs—In a Risk Level II containment laboratory, nasal swabs were 
aseptically removed from their transport vial and the tips were vortexed at high speed for 
30 seconds and then allowed to settle undisturbed for at least 10 minutes.   
One hundred microliters of this suspension were spread onto blood agar 
containing 15μg/mL bacitracin (BAC plates) and incubated overnight at 37ºC.  BAC 
plates were also inoculated with M. haemolytica ATCC strain 33396 and M. glucosida 
ATCC strain 38457 as positive controls.  Colonies with morphology typical of M. 
haemolytica were selected for further analysis, using the BAC plate with M. haemolytica 
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33396 as a reference (round, medium sized, ‘wet’, white-grey colored colonies with some 
degree of hemolysis evident).  Three to 5 colonies were streaked onto BAC plates and 
incubated at 37ºC overnight.  Isolated colonies were rechecked to confirm purity and 
verify that the morphology was similar to the reference plate.  Isolates were then tested 
for oxidase (Oxoid) and a catalase reactions (using 3% hydrogen peroxide).  Isolates 
which were oxidase and catalase positive were prepared for PCR.  Positive (M. 
haemolytica and M. glucosidal) and negative controls were also prepared for each of the 
tests.  Isolates that were identified as presumed-M. haemolytica were stored in 20% 
glycerol stocks at -80ºC until further phenotypic characterization.  Phenotypic tests were 
performed using Rosco diagnostic tablets (Diatabs ®) and compared against phenotypic 
profiles (Angen et al. 2002).  Phenotypic tests performed included alpha-fucosidase, beta-
galactosidase, beta-glucosidase, beta-xylosidase, D-xylose, esculin hydrolysis, indole, L-
arabinose, maltose, mannitol, ornithine decarboxylase, sorbitol, trehalose, and urease.  A 
multiplex PCR assay was used to confirm the presumed-M. haemolytica isolates as 
positive (Alexander et al. 2008).  All M. haemolytica isolates confirmed by PCR were 
tested for susceptibility.   
 
Composite and Individual fecal samples—Individual fecal samples corresponding to 
animals from which M. haemolytica was recovered and all composite fecal samples were 
processed by mixing the Cary-Blair transport medium to create a uniform slurry 
(Alexander et al. 2009).  A sterile cotton swab was used to streak for isolation on 
MacConkey Agar (MAC) and plates were incubated for 24 hours at 37ºC.  Isolates that 
fermented lactose and had appropriate morphology were subcultured on lysogeny broth 
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(LB) plate, incubated at 37ºC overnight and then tested for indole reaction.  A 
presumptive identification of non-type specific E. coli was based on colony morphology, 
lactose fermentation and positive indole reaction.  Up to 3 lactose-fermenting (pink) 
colonies per individual fecal sample and five colonies per composite manure sample were 
selected and archived for susceptibility testing by freezing at -80°C in 30% glycerol.   
    
Antimicrobial Susceptibility Testing—Each isolate included in this analysis was tested for 
susceptibility to panels of antimicrobial drugs by disk diffusion (BioMIC) and broth 
microdilution (Sensititre).  Both procedures were conducted according to protocols of the 
Clinical Laboratory Standards Institute (CLSI 2008).  The antimicrobial drugs included 
on the panels used in this study were designed independently for surveillance purposes, 
and as such were not identical.  The antimicrobial drugs included on both the disk 
diffusion and broth microdilution susceptibility panels were ampicillin, ceftiofur, 
sulfisoxazole, streptomycin, tetracycline, and trimethoprim-sulfamethoxazole.  Only 
isolates which had results for these antimicrobial drugs from both testing methods were 
included in these analyses.  Disk diffusion information was recorded as zone diameter 
and broth microdilution information was recorded as the MIC.  Quality control strains 
used were Escherichia coli ATCC 25922, Streptococcus pneumoniae ATCC 49619, and 
Staphylococcus aureus ATCC 29213. 
 
 
Interpretive criteria—Susceptible, intermediate, and resistant (SIR) designations of M. 
haemolytica were determined using CLSI guidelines for ampicillin (2002) and 
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oxytetracycline (2006).  Interpretive criteria for E. coli were also obtained from CLSI 
guidelines (2005), except for streptomycin, which were based on those used by the 
Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) and 
the National Antimicrobial Resistance Monitoring System (NARMS, CDC 2003).   
 
Data Analysis—Data were evaluated graphically and by calculating descriptive 
statistics.  For analysis purpose, isolate susceptibility was dichotomized as resistant and 
non-resistant (which included both intermediate and susceptible classifications).  
Resistance classification obtained from both testing methods was used to cross-classify 
isolates (i.e. resistant by both methods, non-resistant by both methods, and both 
discordant classifications) (Figure 1).  Using counts of these cross-classifications, 
stochastic latent class analysis modeling  (Markov-Chain Monte Carlo simulation using a 
Gibbs sampler)a was used to estimate the proportion of isolates correctly classified for 
resistance (sensitivity) and the proportion of isolates correctly classified for non-
resistance (specificity) by each testing method, as previously described (Lunn et al. 2000; 
Branscum et al. 2005).  Data were stratified into 2 sample sets based on sample collection 
timing (samples obtained at feedlot arrival, and those obtained from animals that had 
been managed in the feedlot environment for at least 60 days).  These models assumed 
that the two testing methods were conditionally dependent and the code was adapted 
from previously published information 
(http://www.epi.ucdavis.edu/diagnostictests/AB2deptests2popns.html; code available 
upon request).  Convergence of each model was assessed by running six simultaneous 
chains with widely different starting values while monitoring history (time series) plots, 
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autocorrelation plots, and Brooks-Gelman-Rubin plots (Gelman and Rubin 1992).  For 
the final model of each organism (E. coli from individual samples, E. coli from 
composite samples, and M. haemolytica) and antimicrobial drug combination, a single 
chain was run with the weakly informative prior probability distributions.  An initial 
burn-in of 5,000 iterations was discarded and the next 50,000 iterations were used to 
generate posterior probability distributions of the test sensitivities and specificities (Enoe 
et al. 2000; Johnson and Gastwirth 2000).  The median estimates and their 95% 
probability intervals were determined from these posterior distributions regarding the 
proportion of correctly classified isolates for resistance (sensitivity), and for non-
resistance (specificity).  Although there is not a formal method for testing whether point 
estimates for 2 tests were statistically different, an approximate method was used as a 
somewhat objective method for evaluating these comparisons of interest.  Specifically, 
probability intervals which overlapped with the point estimate (median) of the other 
susceptibility test were used as an indication that the antimicrobial susceptibility tests 
were not different from one another in their ability to correctly classify true resistance or 
true non-resistance.  Conversely, probability intervals which did not encompass the point 
estimate (median) of the other test were considered to indicate that there was a 
statistically detectable difference between the tests (assumed probability of Type I error 
<0.05).  Positive and negative predictive values were calculated across a range of true 
resistance prevalence values and then plotted to allow further assessment of information.  
The predictive values of resistance (predictive value of a positive test) and the predictive 
values of non-resistance (predictive value of a negative test) were estimated using 
standard formulas (Thrusfield 2005).  In general, the predictive value of resistance is the 
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proportion of true positives divided by the sum of true positives and false positives, and 
the predictive value of non-resistance is the proportion of true negatives divided by the 
sum of true negatives and false negatives (Figure 1).  These predictive values vary 
dramatically with true resistance and therefore must be considered across a range of 
relevant prevalences. 
 
Prior probability estimates—Beta distributions of probabilities were created with 
softwareb to represent the possible values for the prior antimicrobial resistance 
prevalences of sample set 1 and sample set 2 (Table 1).  For the disk diffusion (test 1) 
susceptibility test, prior probability beta distributions (priors) for sensitivity and 
specificity were also established.  Due to the assumed dependence between the 
susceptibility tests, the priors for the sensitivity and specificity of the broth microdilution 
test (test 2) were conditional on the disk diffusion priors.  The choice of test order for 
conducting the analysis with broth microdilution conditionally dependent on disk 
diffusion was arbitrary.  All priors were weakly informative with effective sample sizes 
(a + b; Table 1) under n=10.  Priors for resistance prevalences of E. coli isolates in 
sample set 1 and sample set 2 were taken from a previous study (Rao et al. 2009).  For M. 
haemolytica isolates, relevant priors were only available for the sample set with higher 
prevalence of resistance (sample set 2).  Therefore, the priors for resistance prevalences 
in sample set 2 were taken from a previous study and the estimates for sample set 1 were 
extrapolated as 5% lower than these estimates (Watts et al. 1994).  Since no sources have 
published estimates of the sensitivity and specificity of disk diffusion or of broth 
microdilution susceptibility tests, the authors arrived at a consensus opinion for 
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reasonable estimates and a lower limit with 95% confidence.  The disk diffusion 
sensitivity and specificity priors were assumed to be equivalent and the conditional 
sensitivity and specificity priors of the broth microdilution test were assumed to be only 
slightly higher, but also equivalent.  These prior estimates were the same for all 





Sensitivity Analysis—The influence of prevalence and sensitivity/specificity priors was 
assessed by running the model with highly informative priors based on the same mode as 
the weakly informative priors that were used (Georgiadis et al. 2003).  Additionally, 
widely varying distributions were created to assess the limits of model convergence.  
Without varying the original priors, starting values for the models were assessed by 
widely varying prevalence as well as sensitivities/specificities separately.  The outcomes 
of the disk diffusion and the broth microdilution antimicrobial susceptibility tests were 
assumed to be dependent.  Correlation between tests was monitored by the calculated 
correlation value for each model.  Additionally, a sensitivity analysis of the dependent 
models was run by assuming complete independence between tests in separate models 








Isolates—A total of 2,316 E. coli isolates from individual animal samples were evaluated 
for susceptibility by both tests, as were 885 E. coli isolates from composite samples, and 
783 M. haemolytica isolates.  Isolates in sample set 1 had widely different apparent 
prevalences of resistance to tetracycline, sulfisoxazole, and streptomycin than in sample 
set 2 (Table 2).  However, the apparent prevalences of resistance to ampicillin, ceftiofur, 
and trimethoprim-sulfamethoxazole were not as disparate between the 2 sample sets 
(Table 2).  Between 20% and 30% of E. coli isolates were resistant to a single 
antimicrobial drug, while <20% of M. haemolytica isolates were resistant to a single 









Test Accuracy—Models for all combinations of organisms and antimicrobial drugs 
indicated that both antimicrobial susceptibility testing methods were very good at 
correctly classifying non-resistance of isolates (specificity; Table 4).  However, the 
classification of true resistance (sensitivity) varied.  As indicated by extremely wide 
probability intervals for classification of true resistance, ceftiofur was not modeled well 






For E. coli isolates cultured from individual animal samples, disk diffusion was 
superior to broth microdilution in correctly classifying non-resistance for 5 of the 6 
shared antimicrobial drugs tested (ampicillin, ceftiofur, streptomycin, sulfisoxazole, and 
tetracycline; Table 4).  Ability to correctly classify true non-resistance to trimethoprim-
sulfamethoxazole was not detectably different between the two susceptibility tests.  Disk 
diffusion was superior to broth microdilution in terms of correctly classifying tetracycline 
resistance.  Conversely, broth microdilution was superior to disk diffusion in correctly 
classifying ceftiofur and streptomycin resistances.  However, the probability intervals for 
detection of true resistance for both ceftiofur and streptomycin were relatively wide.  No 
difference was detected between the two susceptibility tests for correctly classifying 
resistance to ampicillin, sulfisoxazole, and trimethoprim-sulfamethoxazole.  
 Correct classification of resistance and non-resistance in isolates of E. coli from 
composite samples was similar to that of E. coli isolates from individual animal samples.  
No difference was found between the 2 tests in correctly classifying non-resistance for all 
of the 6 antimicrobial drugs tested (ampicillin, ceftiofur, streptomycin, sulfisoxazole, 
tetracycline, and trimethoprim-sulfamethoxazole; Table 4).  In correctly classifying 
resistance, no difference was found between the tests in 4 of the 6 antimicrobial drugs 
(ampicillin, streptomycin, sulfisoxazole, and trimethoprim-sulfamethoxazole).  
Analogous to that of E. coli isolates from individual samples, disk diffusion was superior 
to broth microdilution in correctly classifying tetracycline resistance for E. coli isolates 
from composite samples. 
 Correct classification of true resistance and true non-resistance were not 
detectably different between the antimicrobial susceptibility tests for isolates of M. 
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haemolytica in the 2 antimicrobial drugs tested.  Other shared antimicrobial drugs in the 
panels of disk diffusion and broth microdilution could not be modeled due to the absence 
of detected resistance in one or both of the sample sets.  
 
Predictive Value for Resistance and Non-Resistance—Depending on the 
antimicrobial drug being evaluated and the expected prevalence of resistance, these 
results suggest that there would be substantial differences in the confidence that users 
could have regarding how well these susceptibility tests were correctly classifying 
resistance and non-resistance (Figure 2).  The disk diffusion assay had better ability to 
predict true resistance for ampicillin, streptomycin, and sulfisoxazole than did broth 
microdilution when resistance prevalence in E. coli isolates was low (Figure 2); a similar 
difference was found regarding the predictive value for resistance when evaluating 
tetracycline susceptibility in M. haemolytica isolates.  Conversely, the ability to have 
high confidence in test results indicating non-resistance to these 4 antimicrobial drug and 
organism combinations was substantially better for broth microdilution than disk 
diffusion when resistance prevalence was high (Figure 2).  For example, these estimates 
suggest that in a population of E. coli isolates where the true prevalence of resistance to 
streptomycin resistance was 5%, a disk diffusion test indicating resistance would 
accurately predict true resistance status 92.5% of the time and a broth microdilution test 
would only correctly predict true resistance status 68.6% of the time.  However, when the 
true prevalence of resistance to streptomycin was 70%, a disk diffusion test indicating 
non-resistance would correctly predict true non-resistance status 59.2%, while a broth 
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microdilution test indicating non-resistance would accurately predict non-resistance 



























0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Resistance













Figure 2: Predictive values for resistance and non-resistance to streptomycin by 
disk diffusion and broth microdilution.  The vertical lines represent the true prevalence 
of streptomycin resistance at arbitrary low and high levels to illustrate large differences in 




In contrast, the susceptibility tests for other antimicrobial drugs had predictive 
abilities that were more comparable across a wide range of true prevalence values 
(ceftiofur, tetracycline, and trimethoprim-sulfamethoxazole in E. coli isolates and 
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ampicillin in M. haemolytica isolates; Figure 3).  Though the predictive abilities of the 
two tests were not identical, there are not large, practical differences for these 
antimicrobial drugs regarding the confidence that a user could have in positive or 
negative tests results (resistant or non-resistant, respectively) for these two assays.  For 
example, the difference between the predictive abilities of disk diffusion (71.4%) and 
broth microdilution (56.8%) when the true prevalence of resistance to tetracycline was 
5% is much smaller than this difference for streptomycin (Figures 2 and 3).  Similarly, 
there is only a small difference in the predictive ability for non-resistant test results when 
the true prevalence of resistance to tetracycline was 70% (89.2% for disk diffusion vs. 
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Figure 3: Predictive values for resistance and non-resistance to tetracycline by 
disk diffusion and broth microdilution.  The vertical lines represent the true prevalence 
of tetracycline resistance at arbitrary low and high levels to illustrate small differences in 
predictive values between the 2 antimicrobial susceptibility tests.   
 
Model Convergence and Sensitivity Analysis — Evidence for model convergence was 
provided for each model by the overlapping history (time series) plots for 6 simultaneous 
chains, a relatively immediate drop to zero in autocorrelation plots, and overlapping lines 
with values of ~1 in Brooks-Gelman-Rubin plots (Gelman and Rubin 1992).  Widely 
varied prior probability distributions and starting values had little influence on results 
obtained from all of the models.  Correlation values obtained from the latent class models 
for the 2 tests were low (<0.3) for all models suggesting that there was a low or small 
amount of conditional dependence between the sensitivities and specificities of the tests.  
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Additionally, this conclusion was supported by the fact that parameter estimates obtained 
from models which assumed conditional independence for the classification of true 
resistance and true non-resistance between the two susceptibility tests were generally 
similar to the estimates obtained from models which included parameters for conditional 






Results of this study indicate that the ability of disk diffusion and broth 
microdilution susceptibility tests to correctly classify true resistance varies by the 
antimicrobial drug and organism of interest.  In contrast, both testing methods had 
consistently strong ability to correctly classify true non-resistance for all antimicrobial 
drugs tested and in both E. coli and M. haemolytica.  Therefore, non-resistance detected 
by either method likely represents the true non-resistance status in these populations, but 
more errors in the correct classification of true resistance can be expected.  Additionally, 
misclassification of resistance to different antimicrobial drugs occurs at different rates in 
the 2 organisms.   
Hui and Walter used a maximum-likelihood procedure to develop deterministic 
estimates of error rates and true prevalences in 2 populations assuming conditional 
independence between the tests (1980).  More recently, stochastic methods have allowed 
incorporation of prior knowledge (Bayesian methods) using Monte Carlo simulation to 
estimate posterior probabilities regarding test accuracy and the true prevalence of 
conditions in populations (Enoe et al. 2000).  Additionally, the methodology has been 
extended to account for tests which do not meet the traditional assumption of conditional 
independence (Branscum 2005).  Therefore, theoretically unbiased estimates of the 
accuracies for conditionally dependent tests can be obtained.   
The ability of a test to correctly identify resistance or non-resistance dictates our 
level of trust in describing the true picture of resistance.  Clinically, an accurate 
understanding of true resistance and true non-resistance is important for appropriately 
selecting antimicrobial drugs to control or prevent disease while also adhering to 
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principles of prudent use.  Both broth microdilution and disk diffusion susceptibility tests 
have limitations in their methodology for adequately representing in vivo factors which 
contribute to therapeutic failures, such as stage of infection or physiologic barriers.  
Information obtained from broth microdilution is often considered as more clinically 
relevant than that obtained from disk diffusion because the MIC information can aid 
therapeutic decision making regarding drug selection, dosing, and route of 
administration.  However, this study has shown that misclassification of resistance (and 
non-resistance) in many of the tested antimicrobial drugs was just as likely in broth 
microdilution testing as it was in disk diffusion.  In the case of tetracycline, the broth 
microdilution test was actually shown to be more prone to errors in resistance 
classification than disk diffusion.  A limited number of antimicrobial drugs were 
analyzed in this study, so similar results in untested antimicrobial drugs may also be 
found. 
On a broader scale, surveillance for antimicrobial resistance on a regional, 
national or even international level requires that large numbers of isolates be evaluated to 
help ensure representativeness of results.  Therefore, the cost per test becomes a much 
larger concern when compared to susceptibility testing for clinical purposes.  High 
accuracy in surveillance is necessary to confidently and efficiently respond to potential 
antimicrobial resistance threats to health on a population level (Livermore et al. 1998).  
Given that results for different drugs were largely comparable for disk diffusion and 
broth microdilution, we conclude that there are several advantages which make disk 
diffusion susceptibility testing a more practical choice for use in large surveillance 
programs compared with broth microdilution.  The equipment and supplies necessary for 
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testing by disk diffusion is lower in cost than for testing by broth microdilution.  
Additionally, disk diffusion testing is more flexible in terms of the ability to easily and 
cheaply switch antimicrobial susceptibility discs in the antimicrobial drug panel as 
opposed to producing or ordering customized 96-well plates in broth microdilution 
testing.  The epidemiologic thresholds of emerging resistances are often much lower than 
the clinical breakpoints between resistance and non-resistance (Greiner and Gardner 
2000a; Greiner and Gardner 2000b; Bywater et al. 2006; Simjee et al. 2008).  Since lower 
prevalences of resistance need to be detected, large numbers of isolates must be tested for 
surveillance purposes and costs can become even more prohibitive.  A limitation of this 
study was that clinical breakpoints were used to designate resistance and non-resistance, 
so it is possible that the tests would perform differently at other breakpoints or 
epidemiologic thresholds.  However, the breakpoints utilized here were the ones readily 
available and might practically be used in the development of a surveillance program. 
 Beyond the considerations of test accuracy, the predictive values calculated in this 
study illustrate that the decision of an appropriate test for a certain population could also 
be directed by the expected level of resistance prevalence.  In general, at very low 
prevalences, the predictive value for resistance will always be low while the predictive 
value for non-resistance is high (Thrusfield 2005).  Conversely, at very high prevalences, 
the predictive value for resistance will always be high while the predictive value for non-
resistance is low.  This principle applies generally to all tests and has been previously 
noted as well in the performance of disk diffusion susceptibility testing (Lamy et al. 
2004).  The susceptibility tests in this study had comparable predictive abilities across a 
range of resistance prevalence to some antimicrobial drugs indicating that either test 
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would perform well.  However, the tests would perform differently dependent on the 
prevalence of resistance to antimicrobial drugs such as streptomycin and sulfisoxazole in 
E. coli isolates. 
 Since disk diffusion and broth microdilution are based on similar biological 
mechanisms which measure concentration relationships between the organism and the 
antimicrobial drug, the two tests were assumed to be dependent.  In highly dependent 
tests, the proportions of detecting true resistance or true non-resistance by each test are 
expected to be the same and correlation values would be high (i.e. >0.7).  Correlation 
values in this study were low and analogous models assuming independence of test 
accuracies produced similar posterior probability distributions to those of the dependence 
models.  However, we do not believe that this finding universally exempts us from the 
necessity of assuming dependence between disk diffusion and broth microdilution since 
both tests were highly accurate (Georgiadis et al. 2003).  The dependence models used in 
this study would be recommended to account for any amount of correlation, no matter 
how small (Dendukuri and Joseph 2001).  
One of the assumptions of latent class analysis for 2 tests in 2 populations is that 
the 2 populations have different prevalences (Branscum 2005).  This was a limitation in 
our study for ampicillin, ceftiofur, and trimethoprim-sulfamethoxazole resistance since 
the prevalences of these antimicrobial drugs in sample set 1 were similar to their 
counterparts in sample set 2.  Even tetracycline resistance in M. haemolytica isolates and 
sulfisoxazole resistance in the E. coli isolates from composite samples was suspect for 
this reason as well.  Therefore, the estimates for these antimicrobial drugs should not be 
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considered as reliable as the other antimicrobial drugs with smaller probability intervals 
(Toft 2005).   
The collection of isolates used for this study was a non-representative, 
convenience sample.  Also, multiple isolates were from the same individual or from 
individuals within the same pen and clustering of resistances would be expected in such a 
population.  Therefore, the posterior probability distributions for prevalence produced by 
the models were not reported.  It was not an objective of this study to describe true 
resistance prevalence in the 2 sample sets nor was it necessary for the evaluation of the 
test accuracy by this latent class analysis method.  Every isolate was tested by both 
systems and the effective comparison of the tests was at the isolate level.  Theoretically, 
the proportions of correctly classified true resistance and true non-resistance are constant 
across populations of different resistance prevalences.  Therefore, the estimates produced 
in this study would be relevant in all populations of feedlot cattle for the antimicrobial 
drug and organisms presented. 
The prior probability distributions (priors) used in these models were potentially 
biased due to design differences between this study and the studies which documented 
resistance prevalence in similar populations.  However, the priors were all structured to 
be weakly informative to the Bayesian analyses and were not found to influence the 
models heavily.  The prevalence estimates for antimicrobial drug resistance in E. coli 
isolates for arrival and exit populations were highly relevant since the population of 
feedlot cattle from Alberta were likely very similar to that of our study (Rao et al. 2009).  
The previous study only evaluated resistances by way of composite samples, so the use of 
these same priors for the individual E. coli isolates in our models might be different if 
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more appropriate priors were available.  The M. haemolytica prevalence priors were even 
more biased than the individual E. coli priors.  No other studies have been conducted 
which estimate the level of resistance in representative populations of feedlot cattle for 
M. haemolytica isolates using analogous susceptibility testing approaches.  Therefore, the 
best estimates were obtained from a study of diagnostic laboratory lung samples for 
different respiratory pathogens (Watts et al. 1994).  The resistance detected in lung 
isolates may differ from that of the nasopharyngeal swab isolates used in our study.  The 
biased priors as well as the low level of resistance detected in M. haemolytica most likely 
account for the wide probability intervals for the proportions of correctly classified 




aWinBUGS 1.4, 1996-2003, Imperial College and Medical Research Council, UK: 
http://www.mrc-bsu.cam.ac.uk/bugs/  
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 The veterinary and public health sectors are both interested in the prevalence of 
antimicrobial resistance in food producing animals.  The former has interests in the 
efficacy of antimicrobial drugs in managing these animals as well as the concerns of the 
latter.  The public health sector hypothesizes that the exposures to antimicrobials in food 
producing animals detrimentally affects the susceptibility to antimicrobials in humans.  
Tracing the probabilities of persistence and dissemination of resistance from food-
producing animals to humans is beyond the scope of this project.  However, this project 
does evaluate one of the first steps in this transmission possibility; the development of 
resistance.  Not only is the prevalence of antimicrobial resistance important, but also the 
associations or lack of associations between resistance and exposures to antimicrobial 
drugs. 
This project directly evaluated these associations in feedlot cattle by tracking all 
exposures to parenteral antimicrobial drugs between time points when samples were 
collected, cultured, and tested for susceptibility to panels of antimicrobial drugs.  Due to 
the intensive management of feedlot cattle in groups or pens, the antimicrobial pressures 
applied to an individual in one of these pens might logically apply pressure to other 
individuals in that pen.  Therefore, exposures were tracked for individuals as well as 
calculated on a pen-level basis to evaluate an ecological exposure to antimicrobials in this 
environment.  Accurately evaluating the complex relationships between antimicrobial use 
and resistance has always been challenging with the limited techniques that are available 
to analyze this type of data.  Two different analytical approaches were used in this project 
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to explore options for surveillance programs.  One of these two approaches was found to 






Objectives: The objectives of this study were to 1) estimate the prevalence of 
antimicrobial resistance in the study population and 2) to investigate the associations 
between exposures to parenteral antimicrobial drugs and antimicrobial resistance in fecal 
non-type specific E. coli (NTSEC) recovered from individual feedlot cattle.  
 
Materials and Methods: Two-stage random sampling was used to identify cattle for 
enrollment at 4 western Canadian feedlots.  A fecal sample was collected per rectum 
from each individual at arrival and at a second sampling point around mid-feeding period 
when cattle were rehandled as part of standard production practices.  From samples 
collected at this second time point, a total of 2,133 NTSEC isolates were tested for 
susceptibility to antimicrobial drugs by disk diffusion.  Parenteral exposures to 
antimicrobial drugs were recorded for each individual enrolled in the study as well as for 
other animals in the same pen.  The least square means estimates and 95% confidence 
intervals for the prevalence of resistance at each time point were modeled using Poisson 
regression.  Multivariable logistic regression modeling was used to investigate 
associations between antimicrobial resistance and exposure to antimicrobial drugs.  
Regression models were adjusted for clustering of observations among individuals and 
pens. 
 
Results: The most common resistances identified in arrival samples were sulfisoxazole 
(7.5%; 95%CI: 6.1-9.2), streptomycin (7.7%; 95%CI: 6.3-9.5) and tetracycline (20.0%; 
95%CI: 17.7-22.6).  At the second sampling point, resistance prevalence was 25.6% 
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(95%CI: 23.5-28.0) for sulfisoxazole, 25.0% (95%CI: 22.8-27.3) for streptomycin, and 
72.7% (95%CI: 70.5-75.1) for tetracycline.  Regression modeling identified an 
association between exposures to tetracyclines with antimicrobial resistance to 
tetracycline at the second time point.  Exposures to other classes of drug were not 
associated with increased resistance. 
 
Conclusions:  Parenteral exposures to antimicrobial drugs in feedlot cattle did not drive 






Though the development mechanisms and factors associated with antimicrobial 
resistance are complex and multifactorial, exposure to antimicrobial drugs is considered a 
large contributor to the overall burden of resistance (Witte 2000; Levy and Marshall 
2004).  Specifically, exposures to antimicrobial drugs in agricultural populations and the 
associations with resistance dissemination ultimately to human populations are of 
particular concern (Phillips et al. 2004; Barton 1998; McGeer 1998; Angulo et al. 2004).  
However, associations between exposure to antimicrobial drugs and resistance need to be 
characterized accurately before risk assessments of identified associations can be pursued 
(McDermott et al. 2002).  Surveillance studies of antimicrobial resistance in populations 
of swine, poultry, and cattle have described varying levels of resistance, differences in 
exposure to antimicrobial drugs and management practices, and associations as well as 
lack of associations between resistance and exposures to antimicrobial drugs (Thibodeau 
et al. 2008; Akwar et al. 2008; Checkley et al. 2008).  Additionally, temporal trends have 
been found that show certain antimicrobials may only be associated in a transient fashion 
(Platt et al. 2008; Lowrance et al. 2007).  Continuous surveillance studies are needed to 
monitor changes in resistance prevalence and potential associations with exposures to 
antimicrobial drugs for the collective health of humans and animals (Aarestrup 2005).   
Challenges in conducting antimicrobial resistance surveillance studies are 
numerous (Caprioli 2000).  Quantifying exposures to antimicrobial drugs in a manner 
that accurately represents selection pressures is deceptively complex (Singer et al. 2006).  
Outcome measures of susceptibility testing can be presented in continuous or categorical 
representations, but the differences in detection abilities between these measures is 
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unknown.  Further, analytic techniques for modeling these measures have inherent 
shortcomings.  While exploring the possible analytical approaches to these data, the 
objectives of this study were to estimate the resistance prevalence and to investigate the 
associations between exposures to parenteral antimicrobial drugs and resistance in fecal 







MATERIALS AND METHODS 
 
Overview—All individual and pen-level exposures to parenteral antimicrobial drugs 
were summarized between 2 time points when fecal samples were collected from 
individual feedlot cattle.  These samples were cultured for isolates of non-type specific E. 
coli (NTSEC), which were tested for susceptibility to panels of antimicrobial drugs.  
Resistance to each tested antimicrobial was evaluated separately for associations with 
exposures to different classes of antimicrobials in regression models. 
 
Study Population— All animal handling and sampling procedures were approved prior 
to the initiation of the study by the Animal Care Committee of Feedlot Health 
Management Services (FHMS) and the Institutional Animal Care and Use Committee of 
Colorado State University.   
Cattle (n=5,913) enrolled in this study were managed at 4 western Canadian 
feedlots in south central Alberta under production conditions typical of those used at 
large commercial cattle feedlots throughout western Canada and the U.S.  Feedlots had 
one-time capacities between 15,000 and 20,000 animals, with pens capable of housing 
50-350 animals.  All feedlots had modern cattle handling facilities.  Commercial feedlots 
were purposively selected for participation based on willingness to participate, and their 
ability to collect data about exposures to antimicrobial drugs for individual animals.  
 Candidate animals utilized in the study were procured through the auction market 
system across western Canada.  Various cattle types were fed at these feedlots over the 3 
years including cattle of various entry weights, age classes (calves and yearlings), frame 
sizes, sources (e.g., ranch-direct cattle and back-grounded cattle), and genders (bulls, 
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steers and heifers).  Cattle entering these feedlots typically weighed 500-900 pounds, 
were managed in the feedlot for 120-250 days, and were slaughtered when body weights 
reached 1,250-1,400 pounds.  
 All animals enrolled in the study were subject to standardized animal health 
management and feedlot production procedures as per the protocols developed by health 
and production consultants (FHMS).  In brief, each animal received a unique 
identification ear tag, a growth implant, vaccines to selected bacteria and viruses, and 
topical avermectin anthelmintic for internal and external parasite control.  In animals 
determined to have a higher risk of developing respiratory disease, a parenteral 
antimicrobial drug was administered as part of the prevention strategies for bovine 
respiratory disease (Table 1).  Water and standard feedlot diets were offered ad libitum 
throughout the feeding period; rations were formulated to meet or exceed the National 
Research Council nutritional requirements for feedlot cattle. 
  
Sampling Procedures—Animals were allocated to the study from September 17, 2007 to 
January 16, 2010.  A 2-stage random sampling plan was used to determine which pens and 
animals within those pens were selected for enrollment.  During the enrollment period, 30% of 
all new pens of cattle were randomly selected for inclusion in the study using a pen 
randomization table.  Within each selected pen, 10% of all animals in that pen were then 
randomly enrolled in the study at initial processing using an individual animal randomization 
table.  
  Individual animals enrolled in the trial were sampled twice over the course of the 
study: during initial processing shortly after arrival to the feedlot and in the middle of the 
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feeding period when cattle were re-handled as part of standard feedlot protocols (e.g. for 
replacement of hormonal implants).  At each sampling date, all animals had a 
nasopharyngeal swab sample and a fecal sample collected per rectum.  The 
nasopharyngeal sample was collected in the deep pharynx using a commercially available 
double guarded swab (# J273, Jorgensen Laboratories, Inc, Loveland, CO, USA).  A Cary 
Blair media tube (BBL CultureSwab™, CA90001-038, VWR International, Mississauga, 
Ontario) was used to transport the nasopharyngeal swab.  Individual fecal samples were 
collected per rectum using a new plastic palpation sleeve.  A minimum of 4 grams of 
feces from the rectum of each animal was transferred into a vial containing modified 
Cary Blair transport media (Enteric Transport Medium, 15 ml, Dalynn Biologicals Inc.) 
(Alexander et al. 2009).  All individual animal samples were labeled with the date and a 
unique study number linked to that animal.  Samples were refrigerated in a chilled cooler 
and transported to the microbiology lab (Agriculture and Agri-Food Canada Lethbridge 
Research Station, Lethbridge, Alberta) for further processing by overnight courier.  Each 
sample collected over the course of the trial was assigned a unique identification number 
to ensure blinding of the laboratory staff and uniform labeling of samples.   
 
Laboratory Procedures— To optimize study efficiency regarding the relationship 
between resistance in NTSEC and M. haemolytica for a separate project, only fecal 
samples recovered from animals that also had M. haemolytica isolates recovered from 
their nasopharyngeal swabs were cultured for NTSEC.  Manure samples were processed 
immediately after overnight delivery to the microbiology laboratory.  The feces were 
mixed with the Cary-Blair transport medium to create a uniform slurry (Alexander et al. 
 
 121
2009).  A sterile cotton swab was immersed completely into the sample and then streaked 
onto a MacConkey Agar (MAC) plate.  Plates were incubated overnight at 37ºC.  After 
24 hours of incubation, the MAC plates were removed from the incubator and examined 
for lactose-fermenting (pink) colonies with morphology typical of NTSEC.  Using aseptic 
technique, up to 3 colonies were selected and streaked onto fresh Lysogeny Broth (LB) 
plates and incubated at 37ºC overnight.  Using a single colony from each LB plate, an 
indole test was performed and isolates determined as presumed-NTSEC (lactose-
fermenting, indole-positive) were stored in 30% glycerol stocks at -80ºC until further 
characterization. 
 
Antimicrobial Susceptibility Testing—Each NTSEC isolate included in this analysis was 
tested for susceptibility to a standardized panel of antimicrobial drugs by disk diffusion.  
The antimicrobial drugs included in this panel were ampicillin, amoxicillin-clavulanate, 
ceftazidime, ceftiofur, enrofloxacin, sulfisoxazole, florfenicol, neomycin, streptomycin, 
trimethoprim-sulfamethoxazole, and tetracycline.  Ceftazidime-clavulanate was also 
included in the panel for a separate project investigating occurrence of extended spectrum 
beta lactamases.  Due to interruptions in the availability of antimicrobial discs for 
ceftazidime-clavulanate, not all isolates were tested for susceptibility to this antimicrobial 
drug.  The antimicrobial testing procedures were conducted according to protocols of the 
Clinical Laboratory Standards Institute (CLSI 2008).  Quality control strains used were 
Escherichia coli ATCC 25922, Streptococcus pneumoniae ATCC 49619, and 




Interpretive criteria— Susceptible, intermediate, and resistant (SIR) designations of M. 
haemolytica were determined using CLSI guidelines for ampicillin (2002) and 
oxytetracycline (2006).  Interpretive criteria for E. coli were also obtained from CLSI 
guidelines (2005), except for streptomycin, which were based on those used by the 
Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) and 
the National Antimicrobial Resistance Monitoring System (NARMS, CDC 2003).   
 
Antimicrobial Use Data—Individual animal exposure data regarding antimicrobial 
drugs were recorded at each feedlot over the course of the study using a chute-side 
computer system (iFHMS, Okotoks, Alberta).  Exposures were also recorded for animals 
not enrolled in the study, but housed in the same pen as study animals.  These data 
included the product used, the dose, and the date of administration.  All study data were 
subsequently compiled, collated in a computer spreadsheet and verified.  In-feed 
antimicrobials, ionophores, and coccidiostats were not included in this analysis. 
 
Data Analysis—To facilitate further analysis involving logistic regression, isolate 
susceptibility was dichotomized as resistant and non-resistant (which included both 
intermediate and susceptible classifications).  Dosage information for exposures to 
antimicrobial drugs was converted into an Animal Defined Daily Dose (ADD).  The 
ADD metric represents the number of days of treatment for an animal based on an 
assumed average maintenance dosage.  Dosage conversion to ADD was based on the 
expected length of drug effect as indicated by approved dosages (Table 1).  Aggregate 
(pen-level) exposures to antimicrobial drugs accounted for the number of animals 
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receiving the drug in a pen as well as the total number of animals in the pen.  This density 
of exposure in a pen represented the ecological pressure beyond individual exposure to 
antimicrobial drugs.  All exposures to antimicrobial drugs between arrival and the second 
sampling point were summarized for individuals by class of antimicrobial drug and by 









Descriptive Analysis— Data were evaluated graphically and by calculating descriptive 
statistics (Tables 2-4).  The least square means estimates and 95% confidence intervals 
for the prevalence of resistance at arrival and >60DOF were modeled using Poisson 
regression (Figure 1).  Regression analysis using generalized estimating equation 
methods was used to correct prevalence estimates for lack of independence associated 
with multiple isolates recovered from the same individual and with multiple isolates 
recovered from individuals within the same pen.  Compound symmetry (exchangeable) 
correlation structures nested unique sets of isolates from individuals within each unique 
group (pen) of cattle.  Sampling point (arrival or >60DOF) was used as the predictor 
variable of interest for these analyses, and separate models were developed to estimate 
resistance prevalence for 11 of the 12 antimicrobial drugs evaluated.  It was not possible 
to estimate the prevalence of isolates resistant to ceftazidime-clavulanate, as interpretive 
criteria for this drug are not available.   
For presentation, individual parenteral exposures to antimicrobial drugs were 
further summarized into 3 sub-periods between the arrival and the >60DOF sampling 
points.  Period 1 included exposures to a class of antimicrobial drugs within the 3 days 
prior to the >60DOF sampling point.  Period 2 included exposures to a class of 
antimicrobial drugs between 4 and 14 days prior to the >60DOF sampling point.  Period 
3 included exposures to a class of antimicrobial drugs beyond 14 days prior to the 
>60DOF sampling point.  If exposures exceeding a single day were given just prior to a 
period cutoff, the amount of ADDs attributed to each period were summarized separately 
and included only in their respective categories (Table 5).  Pen-level parenteral exposures 
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were presented as the average ADD exposure per individual and the average ADD 






Table 2:  Number of antimicrobials drugs to which non-type specific E. coli isolates 
were resistant from individual feedlot cattle sampled at arrival (n=1663) and > 60 days 
on feed (>60DOF) (n=2133).  Estimates were not adjusted for lack of independence 
between isolates sampled from the same individuals and between individuals from the 






   
Pan-Susceptible 76.5% (1272) 25.4% (541) 
1 12.9% (215) 37.9% (808) 
2 3.9% (65) 16.7% (357) 
3 4.8% (80) 12.8% (273) 
4 1.1% (19) 5.1% (108) 
5 0.5% (8) 1.8% (38) 
6 0.2% (3) 0.2% (5) 
7 0.0% (0) 0.1% (1) 
8 0.0% (0) 0.1% (2) 
9 0.1% (1) 0.0% (0) 













Figure 1:  Prevalence of resistance.  Adjusted for individual and pen effects, least 
square means estimates of the prevalence of resistance to various antimicrobial drugs 
among non-type specific E. coli isolates obtained from individual fecal samples at arrival 
(n=1663) and at >60 days on feed (>60DOF) (n=2133).  Error bars represent 95% 
confidence intervals *Least square mean prevalences of resistance varied significantly 
















































































































Table 5: Parenteral exposure to antimicrobials in sampled individuals (n=1048).  
The total amount of antimicrobials administered for each period and for the total risk 
period is quantified as Animal Defined Daily Dose (ADD).    DOF = Days on feed. 
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Table 6: Exposure to parenteral antimicrobials in pens.  Sampled individuals 
(n=1048) were housed in pens (n =241) which included a total of 48,216 animals each 
averaging 101.5 risk days.  ADD = Animal Defined Daily Dose.   
 
Class of 
Antimicrobial Pens Exposed (pct) 
Average in Exposed Pens 
ADD per Animal ADD Per Animal - day  
   
Beta lactam 155 (64.3%) 0.0561 0.0006 
Macrolide 133 (55.2%) 0.7301 0.0072 
Phenicol 66 (27.4%) 0.0712 0.0007 
Quinolone 77 (32.0%) 0.0429 0.0004 
Sulfonamide 117 (48.5%) 0.0342 0.0003 
Tetracycline 158 (65.6%) 1.1209 0.0110 





Multivariable Regression Analysis—Separate logistic multivariable models for each 
antimicrobial drug were built using backward elimination and commercially available 
softwarea.  The associations between exposure to antimicrobial drugs and resistance were 
examined through 10 logistic models and 12 linear models.  In order to analytically 
control for the potential lack of independence associated with grouped housing, group 
exposures, etc., unique sets of isolates from individuals were nested within each unique 
group (pen) of cattle using generalized estimating equation methods.  A compound 
symmetry (exchangeable) correlation structure accounted for the lack of independence 
with repeated measures from individuals and pens.   
The predictor variables for the multivariable logistic were the totals of the 
antimicrobial drug exposure summaries.  Predictor variables (12 total) for parenteral 
exposure to antimicrobial drugs were summarized by drug classes (beta lactams, 
macrolides, phenicols, quinolones, tetracyclines, and sulfonamides) for each exposure 
context (individual or aggregate).  Exposures to in-feed antimicrobial drugs, ionophores 
and coccidiostats were not included as potential predictors of antimicrobial resistance.   
The outcome for logistic models was the phenotypic resistance or non-resistance 
of each NTSEC isolate for each antimicrobial drug tested.  Variables were initially 
screened in univariable models to determine which ones would be included in 
multivariable model building using a critical alpha for inclusion of 0.25.  Backward 
selection was then used to identify final multivariable models using a critical alpha of 
0.05.  Final models were assessed for confounding by adding previously eliminated 
variables one at a time and evaluating the change in the estimates of the remaining model 
variables.  If the estimate of a single remaining variable changed by greater than 20%, or 
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if estimates of multiple remaining variables changed by greater than 15%, the 
confounding variable was forced into the model.  First order interactions of all main 
effects were forced into the model based on a critical alpha of 0.05.  Any variables 
displaying characteristics of instability (extreme estimates or confidence intervals) were 
removed from the final model.  Odds ratios, 95% confidence intervals (95%CI), and the 






 A total of 3,796 NTSEC isolates originating from 1,855 individuals in 278 pens 
were included in this analysis.  Of these, 1,663 (43.8%) isolates from 807 individuals in 
205 pens were recovered from samples collected at arrival and 2,133 (56.2%) isolates 
from 1048 individuals in 241 pens were recovered from samples collected at the second 
time point, >60DOF.   
 
Antimicrobial Resistance 
Most arrival isolates (76.5%, 1272/1663) were pan-susceptible to all antimicrobial 
drugs tested (Table 2).  Only 12.9% (215/1663) of arrival isolates were resistant to a 
single antimicrobial drug, most of which were single resistances to tetracycline (10.3%, 
172/1663) (Table 3).  The most common multiple resistance (≥ 2 antimicrobial drugs) in 
arrival isolates were combinations of sulfisoxazole, streptomycin, and tetracycline.  
Fewer (25.4%, 541/2133) isolates collected at >60DOF were pan-susceptible to the panel 
of antimicrobial drugs tested (Table 2).  A greater proportion (37.9% (808/2133) of 
>60DOF isolates were resistant to a single antimicrobial drug, which was also most 
commonly resistance to tetracycline (36.8%; 785/2133) (Table 3).  The top 4 resistance 
patterns in arrival and >60DOF isolates were the same combinations of sulfisoxazole, 
streptomycin, and tetracycline.  Accounting for a lack of independence between isolates 
from the same individual and individuals from the same pen, the adjusted resistance 
prevalence in arrival isolates for sulfisoxazole was 7.5% (95%CI: 6.1-9.2), for 
streptomycin was 7.7% (95%CI: 6.3-9.5) and for tetracycline was 20.0% (95%CI: 17.7-
22.6) (Figure 1).  At the >60DOF sampling point, the adjusted resistance prevalence was 
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25.6% (95%CI: 23.5-28.0) for sulfisoxazole, 25.0% (95%CI: 22.8-27.3) for streptomycin, 
and 72.7% (95%CI: 70.5-75.1) for tetracycline.  All other antimicrobial drugs tested had 
resistance prevalences <10% at both sampling points. 
 
Antimicrobial Drug Use 
In this population, individual parenteral treatment with beta lactams, phenicols, 
quinolones, and sulfonamides was uncommon (Tables 5 and 6).  Tetracyclines and 
macrolides were the most commonly used classes of drug.  Aggregate exposures to 
parenteral drugs occurred in many of the pens, but amounted to very few ADD per 
animal relative to the individual exposures.  Almost all exposures to parenteral 
antimicrobial drugs occurred shortly after arrival to the feedlot (i.e. preceded >60DOF 
sampling by many days in period 3).     
 
Logistic Regression 
Ecological (group-level) parenteral exposures were not associated with resistance 
in NTSEC isolates of the tested animals (Table 7).  For every additional dose (3 ADD) of 
tetracycline given parenterally to an individual, the odds of resistance to tetracycline 
increased by 3.51 (95% CI: 1.37-8.99).  For every additional dose (3 ADD) of beta 
lactam given parenterally to an individual, the odds of resistance to streptomycin was 
lower (Odds Ratio: 0.17, 95%CI: 0.01-2.96).  Parenteral exposure to macrolides, 
phenicols, quinolones, and sulfonamides were not associated with differences in the 
prevalence of antimicrobial resistance.  Complex relationships between exposures to 
antimicrobial drugs and resistance were identified.  Exposures to tetracyclines on the pen-
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level confounded the association between individual exposures to tetracyclines and 
tetracycline resistance.  Additionally, the individual exposure to sulfonamides 
confounded the protective association between individual exposure to beta lactams and 
streptomycin resistance. 
 
Table 7: Final multivariable logistic models of associations between parenteral 
drugs and antimicrobial resistance.  The odds ratios and 95% confidence intervals are 
presented in terms of 3 ADD or 1 treatment of parenteral antimicrobials assuming a 3 day 










     
Tetracycline Individual Tetracycline 3.51 1.37 8.99 0.01 
 Pen-level Tetracycline   0.11 
    
Streptomycin Individual Beta lactam 0.17 0.01 2.96 0.02 
 Individual Sulfonamide   0.19 











Results of this study indicate that parenteral exposures to antimicrobial drugs in 
feedlot cattle did not drive resistance at mid-feeding period.  Individual and ecological 
exposures to these drugs were not associated with increased resistance.  The one 
exception to this was the individual parenteral exposure to tetracyclines which was 
positively associated with resistance to tetracycline in E. coli at mid-feeding period.  
Tetracyclines were one of the most common antimicrobial drugs used in this population 
which is not necessarily the case in other feedlots.  Other studies have found both 
transient and temporal trends with tetracycline resistance in feedlot cattle in the absence 
of exposure to antimicrobials (Morley et al. 2011).  Additionally, confounding factors 
unmeasured in this study such as environmental and management pressures likely 
contribute to this relationship (Berge et al. 2010; McDermott et al. 2002; Barbosa and 
Levy 2000).  Even if causality was supported, this finding may lack practical significance 
in terms of important resistance among pathogenic bacteria since tetracyclines continue 
to be efficacious in feedlot populations for prevention and treatment of bovine respiratory 
disease, prevention of histophilosis, and liver abscess control.    
Using logistic regression to analyze antimicrobial resistance data is heavily 
dependent on interpretive criteria used to classify bacteria as resistant or susceptible, and 
thus models may change if more liberal or conservative criteria are suggested.  In 
surveillance of antimicrobial resistance, epidemiologic cutoffs are often much lower than 
clinical interpretive criteria, so a regression technique capable of detecting a more refined 
change in resistance might be preferred (Bywater et al. 2006, Simjee et al. 2008).  With 
this capability, detection of changing trends in resistance prevalence could be detected 
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earlier.  Regression of a continuous outcome rather than a categorized one would 
theoretically provide more detailed information (Wagner et al. 2003).  However, the 
assumptions of linear regression could not all be strictly followed in these analyses.  The 
outcomes modeled in this study had distributions of zone diameters ranging from closely 
normal (enrofloxacin) to bimodal (any antimicrobial drugs with resistance), or even a 
lack of an identifiable distribution (tetracycline).  Linear regression of the zone diameters 
would be inappropriate since the distributions are non-Gaussian.  Additionally, a 1mm 
difference in zone diameter at the top of the scale (35mm vs. 36mm) and a 1 mm 
difference at the bottom of the scale (7mm vs. 8mm) are not equivalent.  This is to say 
that though zone diameter measurements are continuous, they are not interval data.  A 
log-transformation of the zone diameter did not remedy the relationship between each 
zone diameter.  Finally, a non-parametric rank analysis provided conservative levels of 
significance as well as a reliable estimate indicating the direction of association.  
However, the parameter estimates derived from analysis of rank-transformed data are not 
interpretable in a biologically relevant manner as there is not a uniform difference in 
susceptibility associated with a 1 unit increase in rank.  Linear regression may be a more 
precise analysis technique than logistic regression, but it did not practically make sense in 
this data set to estimate the magnitude of associations. 
Not all isolates in this study were pan-susceptible at the arrival sampling point.  
Thus, the resistance status at arrival should ideally be controlled as a potential 
confounding variable for the association between resistance at the second time point and 
exposure to antimicrobial drugs.  Isolates collected at the 2 sampling points in this study 
were not necessarily from the same individuals.  Initially, a subset analysis of only 
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isolates with matching resistance data from the 2 sampling points was used to investigate 
the arrival resistance status as a covariate.  However, this subset included less than 20% 
of the full dataset.  Another possible approach to including this covariate information for 
the full collection of isolates at the second time point was attempted by categorizing the 
arrival resistance status into 3 levels (resistant at arrival, non-resistant at arrival, and 
resistance status unknown at arrival).  Yet, little information was gained in this dataset 
from this approach and no variables accounting for resistance at arrival were included in 
the final models. 
The lack of independence between isolates from the same individuals and 
individuals from the same pen was expected to account for some of the variability in the 
associations investigated in this study (Wagner et al. 2003b).  Nested effects for 
individuals and pens in this analysis allowed for adjustment to account for this lack of 
independence between individuals and pens.  The authors also expected the baseline 
resistance status of each isolate as well as the extent of the association with exposures to 
antimicrobial drugs to vary, so analysis with random intercepts and random slopes would 
be intuitive.  Additional variability due to the sampled individuals and pens would have 
been accounted for with this methodology and models would have produced estimates 
theoretically closer to the true estimates.  The random coefficient models were not 
possible with this particular data set because the models would not converge to produce 
estimates of association.  However, similar analyses to ours in the future should 
investigate this possibility in other data sets in attempt to further characterize different 
sources of variability.   
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Selection criteria for isolates and feedlots may have biased the conclusions of this 
study.  In an effort to test isolates efficiently within this surveillance program, fecal 
samples were only cultured for NTSEC if M. haemolytica could be cultured from the 
corresponding nasopharyngeal swab from the same individual.  We do not anticipate that 
there is a difference in resistance prevalence in NTSEC isolates between those cultured 
from individuals positive for M. haemolytica and those negative for M. haemolytica.  
However, this assumption should be investigated to support or refute a similar isolate 
selection scheme for future surveillance programs.  The 4 feedlots sampled in this study 
were purposefully selected since they had existing data collection instruments (iFHMS).  
Likely, these feedlots were progressive in more than just their data collection abilities 
which would contribute to a selection bias.  However, for the purpose of developing a 
surveillance program in feedlot cattle, the design and implementation of this study was 
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The collection of the 3 projects presented as part of this dissertation contributes to 
a large, pilot surveillance program in Canada for the feedlot sector.  Surveillance of 
antimicrobial resistance is evolving as we learn more about the prevalence of resistances 
to antimicrobial drugs and the many factors involved in the development, dissemination, 
and persistence of resistance.  Due to the large scale nature of these programs, 
methodologies are necessary which are accurate, yet practical to implement.  Sampling 
and testing strategies must be representative, but not cost-prohibitive.  Investigation into 
the magnitude of associations between risk factors and resistance to antimicrobial drugs 
will help to identify mitigation targets for reducing the burden of antimicrobial resistance.  
The specific gaps in knowledge addressed, conclusions, and limitations of each project 














Project 1: Metrics for quantifying antimicrobial use in beef feedlots 
 
 The primary objective of this project was to investigate the preferences of 
stakeholders for reporting antimicrobial drug use data that are collected from beef 
feedlots.  Specifically, the goal of this survey was to identify a method for presenting 
antimicrobial use data that is easily understood by user groups and that accurately 
portrays drug use data in a meaningful and relevant way.  Therefore, the current 
knowledge gaps addressed by this project were: 
 Accurate quantification of antimicrobials  
 Optimization of methodology and standardization for surveillance programs 
 
 
Project 1 Inference: 
 Choosing an appropriate metric for reporting data regarding antimicrobial use is 
deceptively complex.  
 Evaluation of the target audience is critical to clearly presenting and effectively 
communicating information regarding antimicrobial use.   
 Metrics that are most accurate may need to be carefully and repeatedly explained to 
the audience.  Accuracy and clarity together are difficult to encompass in quantifying 
antimicrobial use data.   
 Quantification of antimicrobial use with metrics which do not account for selection 
pressures distorts discussion regarding the impact of antimicrobial use and cannot be 
used to investigate antimicrobial resistance. 
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 Ideally for antimicrobial resistance surveillance programs, a common quantification 
metric or pairing of metrics would be used in all animal agribusinesses as well as 
within the public health sector for more closely comparable estimates 
 The Animal Defined Daily Dose (ADDD) or a related metric in the form of a rate 
(ADDD per 1000 animals) is recommended for quantifying antimicrobial use in 
antimicrobial resistance surveillance programs. 
 
 
Project 1 Limitations: 
 Surveyed individuals were a convenience sample and the representativeness of the 
sampled individuals to the theoretical target population of experts on antimicrobial 
use and reporting in beef industry could not be validated.   
 If stakeholder groups which were not well represented in this study were included, 
different distributions of responses might be expected.   
 Other metrics could be appropriate, depending on the purpose of the research, how 
the data were collected, the organism being investigated for resistance to 









Project 2: Evaluation of resistance classification accuracy by latent class 
analysis of data from disk diffusion and broth microdilution 
for Escherichia coli and Mannheimia haemolytica recovered 
from feedlot cattle. 
 
The objective of this project was to compare estimates of the sensitivity and 
specificity of disk diffusion and broth microdilution when used for identification of 
antimicrobial resistance in non-type-specific E. coli and M. haemolytica recovered from 
feedlot cattle.  These parameters can be used to better estimate the true prevalence of 
resistance for the combinations of organisms and antimicrobial drugs investigated.  
Additionally, similarities or differences in accuracy between the 2 tests can aid 
investigators in selecting the more practical or superior susceptibility test for surveillance 
programs.  Therefore, the current knowledge gap addressed by this project was: 





Project 2 Inference: 
 The ability of disk diffusion and broth microdilution susceptibility tests in correctly 
classifying true resistance varies by the antimicrobial drug and organism of interest.   
 Non-resistance detected by both methods likely represents the true non-resistance 
status in these populations, but more errors in the correct classification of true 
resistance can be expected.   
 Misclassification of resistance to different antimicrobial drugs occurs at different 
rates in the 2 organisms tested.   
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 The predictive values calculated suggest that the expected level of resistance 
prevalence may dictate a more or less appropriate test for some antimicrobial drugs.   
 Susceptibility testing by disk diffusion is recommended for surveillance programs 
over broth microdilution since it provides comparable accuracy and is more cost-
effective.     
 Latent class analysis (no gold standard) techniques are useful for investigating 
accuracy of susceptibility tests for surveillance programs. 
 Reference-based analysis (assuming broth microdilution as the gold standard) tended 
to overestimate the proportion of correct resistance classification and underestimate 
the proportion of correct non-resistance classification for disk diffusion (results not 
shown).   
 
 
Project 2 Limitations: 
 Clinical breakpoints were used to designate resistance and non-resistance, so it is 
possible that the tests would perform differently at other breakpoints or epidemiologic 
thresholds.   
 The few antimicrobial drugs evaluated in this project were selected due to their 
overlap between the two test panels and do not represent all drugs or drug classes. 
 The difference in the prevalence of resistance between the 2 sample sets necessary for 
the analysis technique was small for some of the organism and drug combinations.  




 The prior probability distributions (priors) used in these models were biased due to 
design differences between this study and the studies which documented resistance 
prevalence in similar populations.  However, the priors were all weakly informative 




















Project 3: Associations between parenteral antimicrobial use and 
antimicrobial resistance in Escherichia coli sampled from 
individual feedlot cattle 
 
 The objectives of this study were to estimate antimicrobial resistance prevalence 
and to investigate the associations between exposures to parenteral antimicrobial drugs 
and antimicrobial resistance in fecal non-type specific E. coli recovered from individual 
feedlot cattle.  These estimates and associations can be used to document the prevalence 
of antimicrobial resistance in feedlot cattle and the impact that antimicrobial drugs used 
has on developing antimicrobial resistance.  Therefore, the current knowledge gaps 
addressed by this project were: 
 Prevalence of resistance in food-producing animals 
 Studies investigating direct associations between antimicrobial use and 
resistance 
 Optimization of methodology and standardization for surveillance programs 
 
 
Project 3 Inference: 
 Antimicrobial resistance prevalences were relatively low in this population of feedlot 
cattle, with the exception of tetracycline resistance at the second time point.   
 When controlling for lack of independence: 
o Individual parenteral exposures to tetracyclines were associated with an 
increase in resistance to tetracycline at mid-feeding period. 
o Parenteral exposure to macrolides, phenicols, quinolones, and sulfonamides 
were not associated with antimicrobial resistance. 
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o Parenteral exposures on the pen-level were not associated with antimicrobial 
resistance. 
 Multivariable logistic regression is an appropriate and useful approach for evaluating 
associations between resistance and exposures to antimicrobial drugs in surveillance. 
 Protective associations and confounding were identified and indicate complex 
relationships between antimicrobial use and antimicrobial resistance. 
 
Project 3 Limitations: 
 Logistic regression analyses were based on clinical interpretive criteria.  Resistance 
estimates and associations with exposure may differ based on other interpretive 
criteria. 
 In feed antimicrobials were administered in this population, but were not summarized 
and included in the association models. 
 Random slopes and random intercepts could not be included in this analysis due to 
lack of model convergence in this dataset. 
 Only non-type specific E. coli isolates sampled from individuals that were positive 
for M. haemolytica were cultured and tested for susceptibility.   
 The resistance status of individuals at arrival could not be included as a covariate 
since few arrival isolates could be matched to isolates from the second sampling point 
(i.e. individuals sampled and tested at arrival were not the same individuals sampled 
and tested at the second time point). 
 The 4 feedlots sampled in this study were purposefully selected which may contribute 


































































































































































































TITLE:  Nasopharyngeal Swab Sampling SOP NO.:  001 
PROJECT MANAGER:  Chelsea Flaig DVM:  Dr. Calvin Booker 
EFFECTIVE DATE:  April 19, 2007 STUDY:  FHMS-445 
BACKGROUND 
The following procedure applies when using the Jorgenson J273 swab for 
nasopharyngeal sampling. 
COLLECTION EQUIPMENT AND SUPPLIES 
i. Study label binder with pre printed labels 
ii. Nasopharyngeal swabs. 
iii. Transport media tubes. 
iv. Blood transport carrying boxes 
v. Gloves – all sizes. 
vi. Eye protection for the collector 
PROCEDURES 
1. Store all unused swabs and transport media tubes at room temperature. 
2. Each swab package consists of one single white nasopharyngeal swab, one clear inner 
swab sheath, one clear thick outer guard sheath, and two spare white end caps (which 
will not be used in this procedure). 
3. Restrain the animal in the chute and secure the head tightly with the head gate.  If the 
nasal cavity becomes bloody it is advised that you take the second sample through the 
opposite nostril. 
4. Sampling can be performed using a single individual to both restrain the animal’s 
head and collect the sample.  Additional individuals may be utilized if needed.   
5. Gauge the approximate length of insertion of the swab by holding the swab against 
the animal’s head from the tip of the nostril to where the white capped end reaches 
the back of the jaw, below the ear. This distance will be approximately 10 to 14 
inches, depending on the size of the animal. Remove the swab apparatus from the 
plastic package and grasp it with the free hand as close to the distance on the swab 
that was just measured. 
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6. Flatten the twist tie allowing it to move freely into the guard sheath. Firmly push the 
inner swab sheath through the white cap on the guard sheath until it breaks the seal on 
the end of the cap. Pull the swab sheath back into the guard sheath before insertion.  
7. The individual should then face in the same direction as the animal.  Using the arm 
and hand closest to the animal, secure the head by bending the head and neck toward 
the sample collector.  This hand will also be used to guide the swab into the nostril 
upon insertion.  Using your free hand, collect the sample as described below.  
8. With the free hand, insert the swab end into the nasal cavity of the nostril to be 
sampled. Direct the swab ventrally (down) and medially (center of head), maintaining 
this direction with the hand holding the nostril. The swab should be inserted to the 
level of the pharynx (approximately 10 to 14 inches as measured above). The swab 
will move freely and smoothly with only moderate pressure. 
9. Caution must be used not to accidentally insert the swab into the false nostril of the 
animal and obtain the sample from there.  The false nostril, which lies medial 
(central) and dorsal (up) on either side of the septum, is a shallow compartment (6 to 
8 inches deep) that could easily be mistaken for the correct collection site.  Directing 
the swab down (rather than up) as it is inserted into the nostril will help to avoid 
insertion into the false nostril. If the swab only enters a very short distance and will 
not easily push in further, you are likely in the false nostril.  Withdraw the swab and 
guide it downwards. 
10. When the swab reaches the level of the pharynx, you will feel it bump up against the 
back of the pharynx. Do not force the swab any further.  At this point, you should be 
close to the distance previously measured out on the sheath. Pull the whole swab back 
approximately one inch.  Hold the swab at that level with the hand that is guiding the 
swab at the nostril.  With the other hand, push the swab and inner sheath out of the 
end of the guard sheath cap. Push the white swab further and rotate the swab with 
your fingers to collect the nasopharyngeal sample.   
11. Pull the swab back into the inner sheath.  Pull the inner sheath back into the guard 
sheath.  Remove the whole apparatus from the nasal cavity.  Make sure that the swab 
is held in such a way that it will not slide out of the end of the guard sheath. 
12. Remove the inner sheath and the swab from the guard sheath, ensuring the swab 
remains inside the inner sheath. 
13. Insert the swab directly into the transport media tube by pushing it through the inner 
sheath.  Cut off the swab (with the bandage scissors) at a level that will contain the 
whole length of the swab within the transport media tube. 
14. Label the transport media tube with the appropriate label. 
15. Place the tube in the transport box and then into the cooler provided. 



















































TITLE:  Pen Floor Composite Fecal Sample 
Collection 
SOP NO.:  002 
PROJECT MANAGER:  Chelsea Flaig DVM:  Dr. Calvin Booker 
EFFECTIVE DATE:  September 7, 2007 STUDY:  FHMS-445 
BACKGROUND 
This procedure describes the pen floor fecal sample collection for surveillance of large 
groups of animals. 
Caution should be taken with regards to the reactions and movements of the cattle to 
ensure worker safety when working in the pens. 
You will be notified by the Research Project Manager (RPM) when to sample from the 
pens.  Two people should attend for safety and assistance purposes. 
EQUIPMENT 
Note:  No ice is required in the coolers for collection, only for shipping purposes. 
1. Fecal cups (for sampling into) 
2. Spoons  
3. Apron for each collector 
4. Labels - pre made 
5. Fecal transport vials 
6. Cooler of appropriate size 
7. Appropriate sized gloves for the collectors 
8. Paper towels 
9. Garbage bags - white kitchen 
10. An assortment of pens and markers 
11. Date stamps 
PROCEDURE 
1. One composite sample of fecal material will be collected from each pen.  Each 
composite will contain 20 different fecal patties. Try to collect from fresh patties. 
 
 173
2. Load up the apron with all equipment needed, plus some extra in case of mishap.  
Also take a white kitchen trash bag for disposal of dirty gloves and spoons (You 
can tie this to your apron). 
3. Walk through the pen collecting samples as you go.  Twenty different samples 
need to be collected per cup, by scooping one level spoonful from each sample 
patty from the pen floor with the spoon. If a fecal patty is somewhat old, scrape 
the top crust off to get to a fresher sample.  Avoid collection of any bedding 
material.  A new spoon must be used for each pen.  
4. The sampling pattern for each pen is as follows: start at the gate and head towards 
the back of the pen collecting samples as you go; then turn and walk along the 
back of the pen, still collecting samples. Once at the far corner, turn and walk 
diagonally back to the gate, collecting the remainder of the samples. 
5. Once a cup is filled, stir the mixture for 1 minute. Transfer approximately 10 
grams into a fecal transport tube and then label the tube. Store the tube in the 













































































TITLE: Allocation Rectal Fecal Sample 
Collection  
SOP NO.:  003 
PROJECT MANAGER:  Chelsea Flaig DVM:  Dr. Calvin Booker 
EFFECTIVE DATE:  April 19, 2007 STUDY:  FHMS-445 
BACKGROUND 
This procedure describes the duties of the sample collector for allocation fecal rectal 
sample collection. 
1. COLLECTION SUPPLIES AND EQUIPMENT: 
a. Study Label Binder - pre printed labels provided by FHMS 
b. A good selection of blue ink pens, markers, and date stamp 
c. Fecal sample containers  
d. OB Sleeves 
e. Plastic disposable gloves - all sizes  
f. Cooler(s) 
g. Frozen ice packs 
h. Paper towels 
i. Garbage bags 
PROCEDURES 
1. COLLECTOR 
a. Animals will be run into the chute one at a time. 
b. Ear tags will be identified.  
c. Collector to put on a clean OB sleeve on the hand used for collection for every 
animal. 
d. No sleeve lube can be used. 
e. A glove should be worn on the non-collection hand.  This hand can be used to lift 
the tail, or touch inanimate objects.  Change it when it becomes excessively 
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contaminated. Do not touch the fecal cup with this hand; otherwise there is a 
chance of cross contamination between samples. 
f. Minimum quantity per fecal sample is 10 grams.   
g. Put the fecal sample into the fecal cup.  Do not touch the inside of the fecal cup at 
any time, other than to deposit or wipe the sample into it and only then with the 
hand that was used to collect the sample. 
h. Hand the fecal cup to the Data Recorder who can wipe off the fecal cup, place the 
lid on it, and attach the label. 
i. When sample collection is complete for the day, place in the fridge (if possible) 
until picked up or delivered to FHMS. 
















































































004 FHMS-445 Sample Submission 
 
* Samples are to be shipped every Sunday evening. The samples will go to the lab in 
Lethbridge to be processed. 
 
* Samples need to be kept cool at all times. The microbes are temperature sensitive 
and overgrowth will occur if the samples get warm. Please leave the samples in the 
fridge, or in a cooler with ice packs, until you are ready to record and ship them. 
 
1) Get the samples out of the walk-in fridge in the Field Services Building. They will 
either be in a cooler or a box. The cooler/box should say FHMS-445 on the top. If 
not, look inside, there should be fecal cups and nasal tubes. 
2) There are two types of individual animal case #s, arrival and exit. 
a. Arrival: F05004066; the 0 behind the 2 digit feedlot ID indicates an arrival 
sample. 
b. Exit: F05100106; the 1 behind the 2 digit feedlot ID indicates an exit 
sample. 
3) Record the fecal sample case #s. eg) F05004066. Place them into a Ziploc bag. 
Keep Arrival and Exit samples separate. Write the type of sample on the bags 
with a marker (Arrival, Exit).  
4) Match the nasal sample case #s to the fecal samples. eg) N05004066. Place them 
into a Ziploc bag (separate from the fecals). Keep the Arrival and Exit samples 
separate. Write the type of sample on the bags with a marker (Arrival, Exit). 
a. For each fecal sample there should be a nasal sample, if there is one but 
not the other please make a note of this on the Case #s and Sample 
Submission forms.  
5) If there are composite samples eg) C050157, record and bag them separate from 
the other fecal samples. Some feedlots bag the composite samples separately from 
the other samples when they are collected. Write composite and the type of 
sample on the bags (Arrival, >60 DOF, Exit). 
a. There are 3 types of composite samples: 
i. Arrival: C050157; the 0 behind the 2 digit feedlot ID indicates an 
arrival sample. The label should might also say Arrival. 
ii. >60 DOF: C051025; the 1 behind the 2 digit feedlot ID indicates a 
>60 DOF sample. The label should also say >60 DOF. 
iii. Exit: C052007; the 2 behind the 2 digit feedlot ID indicates an exit 
sample. The label should also say Exit. 
b. Record all information from the composite label on a separate piece of 
paper. This does not go in the spreadsheet of case #s but is needed for 
sample tracking. Information that will be on the label: Case # and Date. 
Info that may be on the label: Pen #, Lot #, Sort Group, type of sample, 
etc. Please record all information available and leave it on RPM’s desk. 
6) Place ice packs above and below the samples in a clean cooler (not the one from 
the feedlot). The coolers are in a cardboard box for shipping. Use the appropriate 
sized box depending on the amount of samples.  
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7) Open the excel spreadsheet called Case Numbers for Samples Submitted ‘Date of 
shipment’; if there is no spreadsheet please make a new one. 
a. Record all case #s in the spreadsheet. Save the sheet and print 2 copies – 1 
will go with the shipment, the other will be filed (place on RPM’s desk). 
b. Place 1 copy on top of the cooler in the box. 
8) Open the Sample Submission Form for the date of the shipment. If there isn’t one 
please make a new one. 
a. Update the shipment date, shipped by, # of samples, and how many of 
each type of sample (Arrival, Exit). Save and print 2 copies - 1 will go 
with the shipment, the other will be filed (place on RPM’s desk). 
b. Place 1 copy on top of the cooler in the box. Tape the box closed. 
9) Fill out the pre-printed waybill. Add the date, No. of Pieces, Wt. The service is 
Station to Station, Declared value of 0, packaging is a Box. Sign the waybill. 
a. Affix the waybill to the top of the box. 
b. Leave the top copy of the waybill on RPM’s desk along with the copies of 
the case #s and sample submission form. 
10) The labels for the box are in the same folder. Ensure that there are labels on the 
box (From, To, Southbound). 
11) Take the box to Greyhound in High River. The Greyhound is in the Grocery Kart 
store (601 1st St W) by the Beef and Brew Restaurant. Do not take the box to the 
Greyhound in Okotoks; the restaurant is not usually open when samples need to 
be shipped and the bus does not always stop to pick up packages. 
a. The bus leaves for Lethbridge at 9:30 pm. The samples need to be there at 
9:00 pm at the absolute latest. 
b. At Greyhound, place the box on the scale; tell the attendant the package is 













































































APPENDIX 8: M. haemolytica Isolation Protocol 
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